Neurological diseases, wide definition

NEURODIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints G6_NEUINFL G6_NEUATR G6_XTRAPYR NEURODEGOTH G6_DEMYEL G6_EPIPAROX G6_NERPLEX G6_POLYNEU G6_MYONEU G6_CPETAL G6_OTHNEU ST19_INTRACRATRAUMA I9_CEREBVASC	276541
6. Filter based on genotype QC (FinnGen only)	248333

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	NEURODIS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_NEUINFL\|G6_NEUATR\|G6_XTRAPYR\|NEURODEGOTH\|G6_DEMYEL\|G6_EPIPAROX\|G6_NERPLEX\|G6_POLYNEU\|G6_MYONEU\|G6_CPETAL\|G6_OTHNEU\|ST19_INTRACRATRAUMA\|I9_CEREBVASC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neurological diseases, wide definition based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	248333	134617	113716
Unadjusted period prevalence (%)	49.78	47.79	52.14
Median age at first event (years)	54.31	51.69	57.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20887: Matched controls
104873

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

323.3

3865

9863

R52.2

ICD-10 Finland

Other chronic pain

8.9

322.5

590

341

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

320.8

5786

17263

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

320.2

3587

8904

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

94.4

320.2

315

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

316.4

6967

22209

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

316.1

2247

4477

M20.1

ICD-10 Finland

Hallux valgus (acquired)

6.6

315.8

718

565

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

315.5

2000

3736

C10AX09

ATC

ezetimibe; oral

3.1

314.7

1720

2936

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1013.4

313.2

406

SPAT1229

SPAT

Assessment of need for aid

6.4

312.2

728

591

WX002

NOMESCO Finland

Sedation and analgesia

2.6

310.2

2395

4983

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

309.3

395

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

308.8

1464

2273

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

308.6

14714

59169

M01AC06

ATC

meloxicam; systemic, rectal

2.6

307.7

4764

10834

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.0

307.7

2706

3719

M01AB05

ATC

diclofenac; systemic, rectal

2.4

307.7

11350

35161

N03AX11

ATC

topiramate; oral

19.6

307.7

616

162

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

20.1

307.7

2256

628

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5184

13241

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.6

307.7

1218

850

G43.9

ICD-10 Finland

Migraine, unspecified

9.8

307.7

2193

1237

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

23.5

307.7

593

130

N05CF01

ATC

zopiclone; oral

2.4

307.7

4609

10926

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

8.6

307.7

2514

1645

L08

ICPC

Shoulder symptom/complaint

2.5

307.7

3432

7556

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

149.7

307.7

438

X58

ICD-10 Finland

Exposure to other specified factors

2.6

307.7

2923

6124

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

31.1

307.7

677

113

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.2

307.7

2101

3562

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

12.9

307.7

2466

1074

J01DA01

ATC

[U] cefalexin

1.8

307.7

10777

38886

N03AF02

ATC

oxcarbazepine; oral

57.6

307.7

763

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

10645

33335

J01AA02

ATC

doxycycline; systemic

2.1

307.7

13293

47834

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.2

307.7

1474

1881

C09CA06

ATC

candesartan; oral

2.7

307.7

3750

7977

N03AX09

ATC

lamotrigine; oral

5.6

307.7

1256

1186

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

307.7

10301

35835

N02BF02

ATC

pregabalin; oral

8.5

307.7

1150

711

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

24.0

307.7

1127

249

N05AH04

ATC

quetiapine; oral

3.3

307.7

4051

7225

M54.1

ICD-10 Finland

Radiculopathy

12.8

307.7

530

213

G47.3

ICD-10 Finland

Sleep apnoea

22.0

307.7

5377

1627

M03BX02

ATC

tizanidine; oral

2.7

307.7

11631

33267

M54.2

ICD-10 Finland

Cervicalgia

5.1

307.7

1398

1449

N06AX16

ATC

venlafaxine; oral

3.5

307.7

3031

4856

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

5.7

307.7

944

861

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

307.7

3995

10208

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

4078

8576

M01AH01

ATC

celecoxib; oral

3.6

307.7

1947

2886

N89

ICPC

Migraine

5.3

307.7

1302

1310

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.9

307.7

4985

10166

M01AH05

ATC

etoricoxib; oral

2.7

307.7

10887

30055

R4110, ,

SPAT

3.5

307.7

1761

2652

C08CA01

ATC

amlodipine; oral

2.4

307.7

4120

9915

A10BK01

ATC

dapagliflozin; oral

52.0

307.7

749

G40.9

ICD-10 Finland

Epilepsy, unspecified

241.7

307.7

743

A10BH01

ATC

sitagliptin; oral

723.8

307.7

827

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

307.7

4156

7946

P06

ICPC

Sleep disturbance

3.1

307.7

2828

5115

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.3

307.7

1137

1134

N03AF01

ATC

carbamazepine; oral, rectal

10.0

307.7

706

366

SPAT1310

SPAT

Counselling related to known health issue

2.0

307.7

5484

15939

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.5

307.7

4252

7089

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

307.7

4239

9974

A02BC03

ATC

lansoprazole; oral

2.5

307.7

3696

8180

C10AA05

ATC

atorvastatin; oral

2.5

307.7

4672

10677

M70.6

ICD-10 Finland

Trochanteric bursitis

4.6

307.7

1449

1682

A01

ICPC

Pain general/multiple sites

4.2

307.7

1561

1970

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.4

307.7

1149

1113

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

181.2

307.7

459

A10BB12

ATC

glimepiride; oral

102.6

307.7

401

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

4943

11258

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.9

307.7

3629

5430

R51.80

ICD-10 Finland

Headache

4.9

307.7

4120

4961

A07EC01

ATC

sulfasalazine; oral, rectal

12.2

307.7

903

386

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

8.6

307.7

2220

1434

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.6

307.7

3778

6012

B01AB05

ATC

enoxaparin; parenteral

2.3

307.7

3886

9434

B01AC04

ATC

clopidogrel; oral

4.5

307.7

1496

1771

L86

ICPC

Back syndrome with radiating pain

6.2

307.7

890

745

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

121.9

307.7

521

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

9.2

307.7

1997

1190

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

6.8

307.7

1382

1079

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

9.1

307.7

607

343

G43

ICD-10 Finland

Migraine

3.5

307.7

1621

2471

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

307.7

3140

6249

C10AA01

ATC

simvastatin; oral

2.3

307.7

3724

8866

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.1

307.7

1147

1178

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

3503

8416

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.6

307.7

2262

2687

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

307.7

14498

55891

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

56.9

307.7

870

Z3226

NOMESCO Finland

Physiotherapist

3.2

307.7

2693

4606

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

307.7

7337

20143

XA800

NOMESCO Finland

Neuropsychological investigation

10.4

307.7

913

460

C07AA05

ATC

propranolol; systemic

2.6

307.7

4051

8837

T89

ICPC

Diabetes insulin dependent

82.2

307.7

604

E66.8

ICD-10 Finland

Other obesity

6.3

307.7

1089

907

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

5.8

307.7

1062

957

SPAT1301

SPAT

No procedures

2.1

307.7

5163

14359

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

307.7

3339

6900

A28

ICPC

Limited function/disability NOS

3.9

307.7

1746

2419

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.2

307.7

1464

1853

E66.01

ICD-10 Finland

Obesity due to excess calories

4.6

307.7

2068

2422

A02BC05

ATC

esomeprazole; systemic

2.4

307.7

6312

15837

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

307.7

1274

1617

A02BC01

ATC

omeprazole; systemic

2.4

307.7

4006

9509

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

8.9

307.7

759

444

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

22.2

307.7

492

114

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.2

307.7

782

564

WX723

NOMESCO Finland

CPAP therapy

613.3

307.7

934

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.9

307.7

1563

1213

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

54.9

307.7

1728

172

L15

ICPC

Knee symptom/complaint

2.6

307.7

3945

8491

R4120

NOMESCO Finland

Occupational therapy

6.8

307.7

1047

811

R4110

NOMESCO Finland

Physiotherapy

2.7

307.7

4227

8915

215

Kela drug reimbursment

Diabetes, non-insulin-treated

412.6

307.7

2963

A10AE06

ATC

insulin degludec; parenteral

829.1

307.7

476

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.0

307.7

1477

1967

M48.0

ICD-10 Finland

Spinal stenosis

44.2

307.7

1111

133

G51.0

ICD-10 Finland

Bell palsy

40.9

307.7

462

3007

Kela drug reimbursment

Erenumab and fremanezumab

24.2

307.7

406

N06AX21

ATC

duloxetine; oral

6.6

307.7

2311

1945

S06.0

ICD-10 Finland

Concussion

21.1

307.7

3438

968

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

10.6

307.7

630

306

103

Kela drug reimbursment

Diabetes, insulin-treated

254.0

307.7

3213

N06AX11

ATC

mirtazapine; oral

2.7

307.7

6291

14268

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

331.3

307.7

1183

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

12.8

307.7

588

237

M54.4

ICD-10 Finland

Lumbago with sciatica

5.8

307.7

3186

3173

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

153.9

307.7

391

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

8.5

307.7

1552

984

M79.1

ICD-10 Finland

Myalgia

3.3

307.7

2878

4836

WX722

NOMESCO Finland

PEEP

12.2

307.7

619

261

AA1AD

NOMESCO Finland

CT of head and brain

8.2

307.7

4950

3838

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

307.7

7526

18860

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

693

L04AX03

ATC

methotrexate; systemic

9.2

307.7

1214

700

E11

ICD-10 Finland

Type 2 diabetes mellitus

23.2

307.7

1572

366

M79.0

ICD-10 Finland

Rheumatism, unspecified

53.0

307.7

363

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

33.4

307.7

1003

158

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

1277

R06.0

ICD-10 Finland

Dyspnoea

2.9

307.7

4110

8113

C07AB07

ATC

bisoprolol; oral

2.8

307.7

6300

14153

L13

ICPC

Hip symptom/complaint

3.0

307.7

2221

4060

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

307.7

3129

6457

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

307.7

2109

3916

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.9

307.7

2118

2340

M17.1

ICD-10 Finland

Other primary gonarthrosis

12.7

307.7

1985

860

N06AB10

ATC

escitalopram; oral

2.3

307.7

4524

11310

L17

ICPC

Foot/toe symptom/complaint

2.5

307.7

5159

12267

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

8029

25274

N06AB04

ATC

citalopram; systemic

2.7

307.7

3351

6868

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

307.7

2570

4717

ACC51

NOMESCO Finland

Release of median nerve

447.5

307.7

1490

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

11.3

307.7

1269

598

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

747

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.5

307.7

663

299

N03AE01

ATC

clonazepam; systemic

7.2

307.7

845

609

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

15.4

307.7

1273

441

N02BF01

ATC

gabapentin; oral

12.6

307.7

1779

772

R5140

NOMESCO Finland

Monitoring the use of the aid

23.5

307.7

2097

496

N05BA01

ATC

diazepam; systemic, rectal

3.5

307.7

2022

3116

J01DB01

ATC

cefalexin; oral

2.4

307.7

16223

61882

WX320

NOMESCO Finland

Spinalanesthesy

2.5

307.7

2935

6343

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

307.7

2432

4295

M54.3

ICD-10 Finland

Sciatica

7.6

307.7

763

520

N03AX16

ATC

[U] pregabalin

7.6

307.7

3657

2838

A10BK03

ATC

empagliflozin; oral

85.7

307.7

1039

A10AB04

ATC

insulin lispro; parenteral

92.5

307.7

433

P01BA02

ATC

hydroxychloroquine; oral

19.0

307.7

848

233

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

12.1

307.7

1470

653

M25.5

ICD-10 Finland

Pain in joint

4.1

307.7

6011

9356

WX780

NOMESCO Finland

Remote monitoring CPAP

1253.6

307.7

974

N03AX12

ATC

[U] gabapentin; oral

15.9

307.7

2760

994

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

307.7

8871

29665

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

307.7

5002

12441

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1170.2

307.7

466

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

10318

36535

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

692

SPAT1153

SPAT

Removal of sutures

2.4

307.7

4160

9966

OAB50, ,

SPAT

8.1

307.7

1020

660

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

307.7

2888

6118

ZXA05

NOMESCO Finland

Left side

2.7

307.7

2898

5950

M01AX17

ATC

nimesulide; oral

2.7

307.7

2475

5029

C03CA01

ATC

furosemide; systemic

3.0

307.7

2871

5295

X59

ICD-10 Finland

Exposure to unspecified factor

2.8

307.7

3505

6935

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

8.0

307.7

2202

1519

NF1AA

NOMESCO Finland

Hip X-ray examination

10.1

307.7

798

411

G54.0

ICD-10 Finland

Brachial plexus disorders

15.4

307.7

607

203

N02AX02

ATC

tramadol; systemic, rectal

4.2

307.7

7089

11320

H02AB06

ATC

prednisolone; systemic

2.7

307.7

7942

19480

A10AB05

ATC

insulin aspart; parenteral

53.9

307.7

1013

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

332.5

307.7

642

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

123.1

307.7

385

SPAT1216

SPAT

Assessment of functional ability

3.3

307.7

1672

2688

M79.7

ICD-10 Finland

Fibromyalgia

17.2

307.7

579

174

P01AB01

ATC

metronidazole; oral, rectal

2.0

307.7

6635

20065

R20.2

ICD-10 Finland

Paraesthesia of skin

4.5

307.7

1416

1655

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

16.1

307.7

514

164

SPAT1263

SPAT

Sampling

2.0

307.7

7532

23135

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

56.6

307.7

771

R42

ICD-10 Finland

Dizziness and giddiness

3.1

307.7

3545

6464

H04AA01

ATC

glucagon; nasal, parenteral

167.1

307.7

392

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

18.1

307.7

1138

333

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

35.7

307.7

688

100

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

103.3

307.7

1018

A10AE04

ATC

insulin glargine; parenteral

60.7

307.7

1220

107

J01FF01

ATC

clindamycin; systemic

2.3

307.7

4205

10362

ZXA00

NOMESCO Finland

Right side

2.9

307.7

3210

6156

M02AA07

ATC

piroxicam; topical

2.2

307.7

4291

11023

G43.3

ICD-10 Finland

Complicated migraine

34.1

307.7

562

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

307.7

7402

15246

S18

ICPC

Laceration/cut

2.4

307.7

7641

20520

M79.6

ICD-10 Finland

Pain in limb

3.7

307.7

8268

15651

N03AG01

ATC

valproic acid; systemic, rectal

7.1

307.7

1269

953

M54.6

ICD-10 Finland

Pain in thoracic spine

3.9

307.7

1281

1738

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.3

307.7

7475

15221

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

307.7

3319

7058

M03BC01

ATC

orphenadrine (citrate); systemic

3.3

307.7

3932

6970

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

500

L88

ICPC

Rheumatoid/seropositive arthritis

41.2

307.7

363

N05BA04

ATC

oxazepam; oral

2.6

307.7

4717

10474

G56.2

ICD-10 Finland

Lesion of ulnar nerve

16.7

307.7

651

202

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

115.3

307.7

817

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

307.7

5228

13763

M19.0

ICD-10 Finland

Primary arthrosis of other joints

13.7

307.7

1073

413

Z01.8

ICD-10 Finland

Other specified special examinations

3.2

307.7

4044

7266

N03AX14

ATC

levetiracetam; systemic

37.7

307.7

570

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

15.2

307.7

1224

428

A10AB01

ATC

insulin (human); parenteral

145.5

307.7

509

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

307.7

553

N06AA09

ATC

amitriptyline; systemic

6.9

307.7

1093

837

N02BE01

ATC

paracetamol; systemic, rectal

3.5

307.7

17353

60895

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.9

307.7

1945

2141

N01

ICPC

Headache

2.6

307.7

3226

6994

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

52.2

307.7

438

M13.9

ICD-10 Finland

Arthritis, unspecified

9.5

307.7

926

508

NE1AA

NOMESCO Finland

Pelvis X-ray examination

7.2

307.7

701

504

TAB00

NOMESCO Finland

Lumbar puncture

12.4

307.7

1002

426

A10AC01

ATC

insulin (human); parenteral

16.7

307.7

1015

320

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

571.8

307.7

446

L03

ICPC

Low back symptom/complaint

2.8

307.7

5559

12038

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1011.0

307.7

796

M01AX05

ATC

glucosamine; oral

4.3

307.7

1428

1760

L28

ICPC

Limited function/disability (L)

4.8

307.7

2289

2610

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

84.8

307.7

905

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

307.7

3109

6460

Z3231

NOMESCO Finland

Registered nurse

2.3

307.7

4422

10823

M16.1

ICD-10 Finland

Other primary coxarthrosis

20.7

307.7

841

212

R06.5

ICD-10 Finland

Mouth breathing

4.0

307.7

1613

2173

N04BC05

ATC

pramipexole; oral

7.7

307.7

924

624

N02AJ06

ATC

codeine and paracetamol; systemic

3.5

307.7

8238

16599

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.1

307.7

2867

5049

L12

ICPC

Hand/finger symptom/complaint

2.5

307.7

3244

7279

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

35.9

307.7

510

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

101.1

307.7

568

L01

ICPC

Neck symptom/complaint

2.5

307.7

3035

6626

M01AE02

ATC

naproxen; oral, rectal

2.3

307.7

11108

34297

SPAT1262

SPAT

Handing over of treatment supplies

6.4

307.7

2145

1829

A10BJ02

ATC

liraglutide; parenteral

65.3

307.7

358

A10BA02

ATC

metformin; oral

23.4

307.7

3431

872

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

307.7

5152

12521

A10AE05

ATC

insulin detemir; parenteral

186.2

307.7

647

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

45.1

307.7

2604

330

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

7123

12870

E66.00

ICD-10 Finland

Metabolic syndrome

6.8

307.7

746

567

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

18.2

307.7

644

183

G56.0

ICD-10 Finland

Carpal tunnel syndrome

17.0

307.7

2866

973

G44.2

ICD-10 Finland

Tension-type headache

6.0

307.7

3396

3268

R01AD09

ATC

mometasone; nasal

1.9

307.7

8667

28628

A02BC02

ATC

pantoprazole; systemic

3.0

307.7

11942

32103

T90

ICPC

Diabetes non-insulin dependent

23.5

307.7

2681

654

R5110, ,

SPAT

5.1

306.5

873

885

R11

ICD-10 Finland

Nausea and vomiting

3.1

302.8

1652

2815

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

24.3

301.2

362

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

300.3

11714

44170

R02

ICPC

Shortness of breath/dyspnoea

2.8

299.7

2023

3912

G35

ICD-10 Finland

Multiple sclerosis

339.1

299.4

398

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

5.7

298.6

762

687

J01MA02

ATC

ciprofloxacin; systemic

1.9

298.4

5494

16437

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

297.6

2936

6872

Z71.8

ICD-10 Finland

Other specified counselling

1.8

297.2

6563

20847

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

12.2

297.2

458

193

M01AE01

ATC

ibuprofen; systemic, rectal

2.1

296.7

17844

76977

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

294.6

2050

4030

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

294.1

3540

9026

M43.1

ICD-10 Finland

Spondylolisthesis

20.1

293.8

373

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

292.8

1504

2463

N80.9

ICD-10 Finland

Endometriosis, unspecified

20.2

292.7

371

N02AA05

ATC

oxycodone; systemic

2.8

292.6

1881

3536

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

12.3

289.8

445

186

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

23.0

288.7

352

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1870.1

288.0

371

G43.8

ICD-10 Finland

Other migraine

12.7

287.2

433

174

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

286.4

2165

4446

A10AA02, ,

ATC

245.6

286.0

385

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

57.6

285.4

294

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

284.9

2695

6179

T82

ICPC

Obesity

5.0

284.8

824

848

N80.1

ICD-10 Finland

Endometriosis of ovary

39.4

284.4

309

H03BB01

ATC

carbimazole; oral

20.9

283.9

356

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

281.6

3576

9302

XCK10

NOMESCO Finland

Photography of fundus of eye

4.4

281.4

952

1134

W19

ICD-10 Finland

Unspecified fall

3.0

281.2

1593

2775

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

4.2

280.7

1001

1248

A04

ICPC

Weakness/tiredness general

2.2

280.0

3023

7349

M23.8

ICD-10 Finland

Other internal derangements of knee

8.3

278.3

530

326

UJF32

NOMESCO Finland

Coloscopy

2.2

277.9

3115

7693

R05

ICPC

Cough

2.0

277.7

4433

12567

OAB93, ,

SPAT

3.0

277.2

1603

2827

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.2

275.9

1413

2307

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

275.5

5384

16359

R60.0

ICD-10 Finland

Localized oedema

3.2

275.3

1454

2422

C10AA07

ATC

rosuvastatin; oral

2.0

274.6

3922

10667

C07AB02

ATC

metoprolol; systemic

2.6

274.2

2102

4343

ZXE00

NOMESCO Finland

One hour or less

1.8

273.4

6234

19894

WX290

NOMESCO Finland

Other blockage of nerve

1.7

272.7

10301

38059

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

41.4

272.0

293

C09AA05

ATC

ramipril; oral

2.4

271.9

2402

5325

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

271.2

1799

3437

J01FA06

ATC

roxithromycin; oral

1.8

269.8

5900

18567

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

207.2

269.7

366

M03BX01

ATC

baclofen; systemic

23.2

269.6

328

XG466

NOMESCO Finland

Sleep oxymetry

13.8

267.5

389

144

PA6AD

NOMESCO Finland

CT of neck arteries

8.8

267.2

490

284

J01CA04

ATC

amoxicillin; systemic

1.9

266.8

16685

71015

M01AH02

ATC

rofecoxib; oral

3.6

266.5

1147

1658

L01BA01

ATC

methotrexate; systemic

23.5

266.4

323

SPAT1254

SPAT

Administration of medicine

2.4

265.7

2437

5496

L90

ICPC

Osteoarthrosis of knee

8.2

265.1

511

320

N02CC07

ATC

frovatriptan; oral

4.2

264.7

937

1160

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

264.5

338

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

261.2

2860

6979

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.5

259.7

837

954

SPAT1260

SPAT

Consultation of another employee

2.3

259.1

2669

6341

M65.3

ICD-10 Finland

Trigger finger

7.1

259.1

551

397

N06AX12

ATC

bupropion; oral

2.8

258.4

1732

3325

G30.1

ICD-10 Finland

Alzheimer disease with late onset

10.7

258.2

425

204

205

Kela drug reimbursment

Chronic hypertension

2.4

257.6

2243

4931

L11

ICPC

Wrist symptom/complaint

2.7

257.4

1855

3705

E66

ICD-10 Finland

Obesity

3.6

256.0

1088

1557

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.9

254.9

1005

1358

R01AD12

ATC

fluticasone furoate; nasal

1.8

254.9

6251

20307

N02CC03

ATC

zolmitriptan; nasal, oral

3.6

253.5

1083

1556

M22.4

ICD-10 Finland

Chondromalacia patellae

9.7

253.3

438

230

B01AF01

ATC

rivaroxaban; oral

3.7

252.7

1047

1470

A10AA01, ,

ATC

287.0

252.6

338

XA402

NOMESCO Finland

ENMG

21.5

252.0

313

M47.9

ICD-10 Finland

Spondylosis, unspecified

33.2

250.9

281

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

84.3

250.9

249

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

250.5

1278

2078

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

215.7

250.2

339

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

250.0

901

1132

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

248.8

318

N05CF02

ATC

zolpidem; oral

2.3

248.8

2574

6120

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1610.8

248.7

321

N02CD03

ATC

fremanezumab; systemic

27.3

248.4

290

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.2

247.5

367

142

A10BH05

ATC

linagliptin; oral

833.3

246.6

321

N06AB06

ATC

sertraline; oral

2.4

246.6

2288

5178

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

246.0

2321

5293

H03AA01

ATC

levothyroxine sodium; systemic

2.1

245.9

3048

7814

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

35.5

245.9

272

R52.9

ICD-10 Finland

Pain, unspecified

2.8

245.3

1581

2966

N06AB03

ATC

fluoxetine; oral

2.5

244.1

1969

4164

J01FA10

ATC

azithromycin; systemic

1.7

243.3

11343

43796

M47.82

ICD-10 Finland

Other spondylosis, cervical region

13.8

242.2

352

130

SPAT1377

SPAT

Polysomnography

7.9

241.5

476

308

R06AE07

ATC

cetirizine; oral

1.7

240.7

8144

28872

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.0

240.6

695

713

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.4

240.6

497

344

R03DC03

ATC

montelukast; oral

2.2

239.7

2760

6861

109

Kela drug reimbursment

Multiple sclerosis

+∞

239.4

306

R50.9

ICD-10 Finland

Fever, unspecified

2.2

238.9

2649

6482

ZXD05

NOMESCO Finland

Urgent procedure

1.8

238.5

4975

15321

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

34.5

238.4

265

R01AD58

ATC

fluticasone, combinations; nasal

1.8

237.4

5053

15657

N06DX01

ATC

memantine; oral

7.4

237.3

490

339

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

236.3

1753

3549

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

236.2

4942

15226

K02.1

ICD-10 Finland

Caries of dentine

1.6

236.2

12044

47431

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

40.5

235.8

255

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

235.5

301

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

34.9

235.3

261

M54

ICD-10 Finland

Dorsalgia

2.4

235.2

2195

4975

SPAT1283

SPAT

Restricted health certificate

1.9

234.9

4415

13138

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

234.3

2058

4533

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

9.4

234.3

413

224

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

234.0

6661

22474

R74

ICPC

Upper respiratory infection acute

1.7

232.8

7602

26626

L16

ICPC

Ankle symptom/complaint

2.4

232.7

2174

4929

R07.3

ICD-10 Finland

Other chest pain

2.8

232.5

1470

2725

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

232.3

2317

5411

N02CC04

ATC

rizatriptan; oral

3.3

231.7

1145

1821

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

231.1

2257

5220

SFA10

NOMESCO Finland

One-surface restoration

1.6

230.6

10798

41495

D01

ICPC

Abdominal pain/cramps general

2.2

230.0

2536

6184

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1486.8

229.9

297

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1486.8

229.9

297

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

22.1

228.7

282

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

228.7

5239

16573

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

23.5

228.5

277

L02

ICPC

Back symptom/complaint

2.4

227.9

1964

4284

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

227.7

2963

7724

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

41.5

227.5

245

J02AC01

ATC

fluconazole; systemic

1.7

226.5

6341

21251

N06AX26

ATC

vortioxetine; oral

2.6

226.1

1717

3516

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

226.0

289

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

225.8

1935

4209

A02BA02

ATC

ranitidine; systemic

2.4

225.3

2094

4732

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

11.6

224.6

354

156

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

38.7

224.0

244

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

22.2

223.4

275

A46

ICD-10 Finland

Erysipelas

2.6

223.0

1642

3308

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

7.6

222.6

450

302

R51

ICD-10 Finland

Headache

3.1

222.3

1227

2095

SPAT1240

SPAT

Therapeutic discussion

2.2

222.1

2428

5893

P20

ICPC

Memory disturbance

3.5

221.3

980

1443

N05AX08

ATC

risperidone; systemic

2.9

221.3

1302

2312

M45

ICD-10 Finland

Ankylosing spondylitis

53.1

221.1

230

WX111

NOMESCO Finland

Local infiltration anesthesia

109.1

220.6

215

C09CA01

ATC

losartan; oral

2.1

220.2

2664

6741

R01AD08

ATC

fluticasone; nasal

1.8

220.2

4915

15397

Z2445

NOMESCO Finland

Psychologist

3.6

220.1

952

1378

A10BD07

ATC

metformin and sitagliptin; systemic

737.1

220.0

287

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

219.8

281

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.0

219.4

632

646

E66.9

ICD-10 Finland

Obesity, unspecified

4.9

219.2

652

688

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

7.8

217.8

432

282

SPAT1097

SPAT

Recording of ECG

2.7

216.6

1532

3019

M02AA10

ATC

ketoprofen; topical

2.4

216.6

1867

4069

WX402

NOMESCO Finland

General anaesthesia

1.9

216.1

3708

10668

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.4

215.7

1950

4346

Z2446

NOMESCO Finland

Social worker

3.0

214.9

1229

2144

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

214.4

1397

2631

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

72.7

213.9

215

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.2

212.5

1106

1818

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.6

212.0

1565

3154

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1368.3

211.9

274

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

211.7

4339

13216

A10BB01

ATC

glibenclamide; oral

67.8

211.5

214

R55

ICD-10 Finland

Syncope and collapse

2.7

210.7

1454

2826

D11

ICPC

Diarrhoea

2.1

210.3

2479

6200

SFA20

NOMESCO Finland

Two-surface restoration

1.6

209.7

11140

43730

OAA65, ,

SPAT

1.8

209.6

4455

13718

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

63.5

209.1

213

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

208.6

1222

2162

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

208.3

1386

2640

N02CD01

ATC

erenumab; parenteral

32.9

207.6

233

N17

ICPC

Vertigo/dizziness

2.4

207.6

1790

3898

M35.7

ICD-10 Finland

Hypermobility syndrome

17.0

206.7

277

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

206.2

1757

3804

H02AB04

ATC

methylprednisolone; systemic

2.4

206.2

1779

3875

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

206.2

3514

10070

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

202.9

206.1

280

M10.9

ICD-10 Finland

Gout, unspecified

5.3

205.4

559

539

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

205.1

4065

12236

M04AA01

ATC

allopurinol; systemic

3.2

205.0

1045

1694

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

33.2

204.5

229

A06AD11

ATC

lactulose; oral

2.5

204.3

1635

3432

J01FA09

ATC

clarithromycin; systemic

1.7

204.2

5030

16165

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.5

203.7

911

1350

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

+∞

203.3

260

A03

ICPC

Fever

1.8

203.2

3911

11659

N02CC06

ATC

eletriptan; oral

3.9

203.2

778

1025

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

14.2

203.0

291

104

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

37.5

202.8

222

E10

ICD-10 Finland

Type 1 diabetes mellitus

275.2

202.2

271

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

1301.4

201.7

261

D07AC01

ATC

betamethasone; topical

1.7

201.7

5611

18650

T90.5

ICD-10 Finland

Sequelae of intracranial injury

64.6

200.6

204

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.1

200.4

389

246

M67.4

ICD-10 Finland

Ganglion

3.3

199.4

966

1513

C08CA13

ATC

lercanidipine; oral

2.8

199.4

1278

2382

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.2

199.1

1003

1613

L04AB01

ATC

etanercept; parenteral

90.3

198.5

196

P03

ICPC

Feeling depressed

2.1

196.3

2587

6748

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.1

195.8

1065

1799

SFA30

NOMESCO Finland

Three-surface restoration

1.6

195.4

6683

23421

L29

ICPC

Musculoskeletal sympt/complt other

2.8

194.9

1265

2374

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

53.9

194.6

202

G44.0

ICD-10 Finland

Cluster headache syndrome

20.1

194.3

246

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

191.1

193.7

264

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

193.5

5494

18326

CL2S4, ,

SPAT

66.2

193.2

196

M77.1

ICD-10 Finland

Lateral epicondylitis

2.7

192.2

1288

2460

ZYC01

NOMESCO Finland

Remote contact by phone

3.0

191.9

1101

1922

N02CC05

ATC

almotriptan; oral

3.7

191.5

796

1117

ZXA10

NOMESCO Finland

Bilateral

2.1

191.5

2265

5659

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.0

191.2

549

559

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

37.8

191.2

209

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

191.1

7862

28803

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

190.5

679

843

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

10.6

190.5

314

151

SGA01

NOMESCO Finland

Emergency treatment

1.9

190.0

3145

8899

B01AA03

ATC

warfarin; systemic

2.4

189.9

1609

3469

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

40.0

189.2

205

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.4

188.8

1709

3802

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

188.6

741

996

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

187.8

2195

5456

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

187.7

3332

9649

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.9

187.6

1157

2108

K90

ICPC

Stroke/cerebrovascular accident

162.5

186.8

257

H53.1

ICD-10 Finland

Subjective visual disturbances

2.9

186.7

1091

1925

Z50.1

ICD-10 Finland

Other physical therapy

5.1

186.5

532

538

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

186.0

1132

2046

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

617.0

185.7

243

R03BA05

ATC

fluticasone; inhalant

1.9

185.6

3090

8755

S80.0

ICD-10 Finland

Contusion of knee

2.6

184.9

1342

2675

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

184.7

1990

4780

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

184.4

2562

6806

ACC53

NOMESCO Finland

Release of ulnar nerve

611.8

184.1

241

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

183.7

235

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

250.5

183.6

247

G04BD12

ATC

mirabegron; oral

2.9

182.9

1082

1923

P29

ICPC

Psychological sympt/compl other

2.2

182.1

1967

4729

R96

ICPC

Asthma

2.5

181.8

1413

2917

P76

ICPC

Depressive disorder

2.4

181.8

1542

3324

N18

ICPC

Paralysis/weakness

36.2

181.5

200

N06AA10

ATC

nortriptyline; systemic

12.1

181.5

280

118

WZC30

NOMESCO Finland

Teaching

2.1

181.1

2088

5157

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

180.9

4229

13318

E0000UV, ,

ATC

1.6

179.8

7362

26831

A29

ICPC

General symptom/complaint other

2.2

179.7

1872

4430

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

179.7

3640

10979

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.6

179.4

560

618

G45.3

ICD-10 Finland

Amaurosis fugax

65.8

179.3

182

R13

ICD-10 Finland

Dysphagia

3.3

179.1

851

1314

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

177.5

1142

2130

G50.0

ICD-10 Finland

Trigeminal neuralgia

14.5

177.4

252

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

15.3

177.4

247

M22.0

ICD-10 Finland

Recurrent dislocation of patella

21.5

177.1

220

M43.0

ICD-10 Finland

Spondylolysis

30.9

176.9

201

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004588) Protein electrophoresis panel - Serum or Plasma

1071

1266

4.42

319.96

2.1

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1597

2579

3.28

318.28

1.9

1.24

1.36

g/l

1.17

1505

2417

(3019150) Specific gravity of Urine by Refractometry

5125

14761

1.98

312.46

3.8

2.3

1.61

1.25

kg/l

0.37

3400

8688

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

879

881

5.19

312.12

2.0

1.2

1.19

1.16

g/l

1.51

841

840

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

846

818

5.37

310.96

2.5

2.3

372.15

363.64

ug/l

0.04

783

775

(3024354) Oxygen [Partial pressure] in Venous blood

1786

3152

3.02

309.66

4.7

3.9

4.78

4.75

kpa

0.15

1739

3066

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

856

847

5.25

307.72

2.0

1.2

0.23

g/l

0.57

817

802

(3023420) DNA double strand Ab [Units/volume] in Serum

1071

956

5.87

307.65

2.1

1.3

7.01

5.54

iu/ml

0.41

270

124

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7299

15368

3.13

307.65

3.4

2.1

54.26

60.73

ng/l

0.15

4101

7229

(3013826) Glucose [Moles/volume] in Serum or Plasma

12002

30577

3.28

307.65

5.7

3.8

6.44

5.96

mmol/l

105.08

11342

27249

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1130

454

13.15

307.65

1.6

1.5

461.72

422.34

mg/l

1.34

1078

433

(3015377) Calcium [Moles/volume] in Serum or Plasma

6440

17254

2.26

307.65

3.0

3.9

2.35

2.36

mmol/l

6.21

5980

15965

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2323

4251

2.96

307.65

1.9

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

14365

55578

1.95

307.65

3.8

2.5

43.07

34.25

u/l

33.26

13801

53250

(3000850) Epithelial cells [#/volume] in Urine

4571

10051

2.64

307.65

2.8

2.0

6.70

6.67

e6/l

0.03

4187

8797

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1002

408

12.90

307.65

1.6

1.4

3.60

3.40

mmol/l

5.49

948

388

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17615

67807

2.94

307.65

5.9

3.7

1.77

1.83

mu/l

2.27

16849

63593

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2202

3828

3.11

307.65

9.3

8.3

5.10

kpa

0.09

2125

3673

(3009261) Glucose [Presence] in Urine by Test strip

10828

34329

2.21

307.65

4.0

2.5

0.15

0.00

estimate

0.58

2248

6308

(3022096) Basophils/Leukocytes in Blood

9965

27503

2.57

307.65

7.3

5.0

0.67

0.68

0.18

9456

25767

(36304419) Bacteria [Presence] in Urine

5471

13925

2.32

307.65

3.3

2.4

0.53

0.21

estimate

0.32

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

14485

43625

3.18

307.65

4.5

2.3

9.69

8.61

mm/h

18.54

13753

40461

(3013512) EKG study

5673

13787

2.46

307.65

3.2

2.4

0.62

0.69

0.19

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2719

5070

2.95

307.65

7.1

5.6

1.07

mmol/l

0.06

2547

4705

(3027801) Oxygen [Partial pressure] in Arterial blood

2203

3826

3.11

307.65

9.3

8.3

13.05

14.26

kpa

12.41

2127

3672

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1083

1009

5.63

307.65

1.3

1.1

0.63

0.50

u/ml

0.15

(3022948) Iron [Moles/volume] in Serum or Plasma

3485

7448

2.62

307.65

2.7

1.9

14.28

14.80

umol/l

2.90

3265

7010

(4027681) Cerebrospinal fluid IgG ratio and IgG index

404

23.76

307.65

1.2

0.70

0.50

ratio

5.20

236

(3030467) Casts [#/volume] in Urine by Automated count

5619

14231

2.34

307.65

3.4

2.4

0.32

0.46

e6/l

3.37

4153

9191

(3018010) Neutrophils/Leukocytes in Blood

10153

28593

2.52

307.65

7.1

4.7

56.34

55.58

7.84

9807

27416

(3029937) Albumin [Presence] in Urine by Test strip

5931

16639

2.10

307.65

4.1

2.5

0.00

estimate

1.06

2220

5914

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3402

7103

2.68

307.65

4.2

0.82

0.83

mmol/l

2.51

3221

6790

(3031040) Bacteria [#/volume] in Urine by Automated count

12873

43257

2.29

307.65

4.8

3.1

1857.11

1001.81

e6/l

0.87

194

486

(3001604) Monocytes [#/volume] in Blood

10858

29729

2.74

307.65

7.1

4.8

0.56

0.55

e9/l

6.91

9574

25366

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

523

153

17.58

307.65

1.1

1.0

—

(3044889) 12 lead EKG panel

12616

42031

2.28

307.65

3.7

2.5

0.38

8036.97

0.50

(3019198) Lymphocytes [#/volume] in Blood

11096

31036

2.70

307.65

7.2

4.8

2.02

1.99

e9/l

0.67

9998

27215

(3002030) Lymphocytes/Leukocytes in Blood

10287

29276

2.51

307.65

7.2

4.8

29.19

30.01

10.51

9869

27851

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10913

37982

1.93

307.65

3.5

2.7

93.55

86.20

ug/l

2.75

10360

36323

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4402

6748

3.88

307.65

1.4

1.1

22.55

14.09

iu/ml

7.56

1184

1737

(3006504) Eosinophils/Leukocytes in Blood

9976

27531

2.57

307.65

7.2

4.9

2.81

2.88

1.96

9470

25857

(3044640) Blood type and Crossmatch panel - Blood

6445

19683

1.93

307.65

2.5

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9179

26622

2.30

307.65

2.7

2.0

72.07

73.62

nmol/l

5.27

8566

25032

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3214

6759

2.64

307.65

2.7

1.9

2.43

g/l

0.12

2997

6283

(3035350) Ketones [Presence] in Urine by Test strip

10806

33973

2.24

307.65

4.0

2.5

7.77

1.33

estimate

2.26

2372

6318

(3023103) Potassium [Moles/volume] in Serum or Plasma

18637

71695

3.83

307.65

17.3

8.3

3.94

3.92

mmol/l

14.74

18332

69048

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8033

20479

2.58

307.65

2.0

1.6

97.64

96.52

pmol/l

1.23

4485

11120

(3042936) Bacteria identified in Isolate by Culture

2917

6022

2.66

307.65

2.2

1.6

—

(3026008) Bacteria identified in Urine by Culture

5729

14889

2.28

307.65

2.9

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

10686

33560

2.23

307.65

3.9

2.5

0.00

estimate

0.83

2345

6343

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1719

1958

4.71

307.65

4.4

5.4

5.15

5.04

kpa

4.35

1664

1868

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1498

1787

4.46

307.65

4.5

5.6

1.28

1.38

mmol/l

0.41

1100

1251

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1883

2562

3.96

307.65

1.3

1.2

45.68

52.61

au/ml

0.47

240

(3012516) Albumin [Mass/volume] in Urine

5070

7947

3.91

307.65

3.8

1.8

62.88

58.59

mg/l

0.36

3439

4203

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16536

65258

2.31

307.65

5.8

2.7

38.27

35.25

mmol/mol

304.27

15843

61718

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2929

6042

2.67

307.65

2.8

2.0

23.69

24.54

2.06

2741

5659

(40758558) Short blood count panel - Blood

6031

17629

2.01

307.65

6.4

5.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3394

5655

3.40

307.65

2.9

2.5

29.46

29.90

3.20

3291

5515

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2082

3751

2.98

307.65

5.1

4.0

5.88

5.80

kpa

2.31

2027

3655

(3015736) pH of Urine

8851

26559

2.17

307.65

3.5

2.3

6.23

0.12

5157

14846

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6203

16940

2.19

307.65

1.4

1.3

1.74

2.09

u/ml

0.91

1779

4792

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7115

18226

2.46

307.65

3.6

2.4

2.22

2.84

e6/l

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8560

21206

2.74

307.65

5.1

4.8

36.84

36.87

g/l

0.13

8091

19942

(3008898) HLA-B27 [Presence]

1170

1229

5.00

307.65

1.1

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4042

5717

4.16

307.65

1.3

1.1

6.61

1.61

u/ml

7.62

1622

2410

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7559

20339

2.36

307.65

3.5

3.0

31.29

32.11

u/l

0.35

7199

19500

(3026493) Urate [Moles/volume] in Serum or Plasma

4856

10949

2.60

307.65

2.6

2.1

330.60

325.69

umol/l

2.42

4362

10145

(3044290) Cell count panel - Cerebral spinal fluid

927

387

12.54

307.65

1.8

1.6

—

(3012544) pH of Venous blood

2089

3814

2.94

307.65

5.1

4.1

7.37

7.38

1.59

1254

2121

(3006315) Basophils [#/volume] in Blood

10879

29742

2.75

307.65

7.1

4.8

0.04

e9/l

3.41

9589

25398

(3002582) Erythrocytes [#/volume] in Urine

6521

16502

2.43

307.65

3.5

2.4

69.99

101.31

e6/l

0.91

5018

11329

(3013115) Eosinophils [#/volume] in Blood

11203

31116

2.74

307.65

7.4

5.1

0.19

e9/l

1.03

10035

26959

(3018418) pH of Serum or Plasma

5638

12260

2.79

307.65

4.1

3.4

7.40

0.26

4016

8019

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17020

68831

2.30

307.65

4.7

2.9

5.81

5.39

mmol/l

291.59

16071

64468

(3037522) Nuclear Ab [Titer] in Serum

3643

5160

4.08

307.65

1.4

1.3

485.33

413.69

titre

1.11

683

745

(3009343) pH of Capillary blood

1676

1929

4.66

307.65

4.4

5.5

7.41

2.14

1406

1584

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4350

8817

2.87

307.65

3.4

2.6

1141.99

936.41

ng/l

1.90

3520

7359

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6680

8790

5.14

307.65

2.4

1.7

259.23

195.69

u/l

1.63

6412

8277

(3003396) Base excess in Arterial blood by calculation

2174

3837

3.06

307.65

9.4

8.3

0.90

0.56

mmol/l

3.20

1762

3149

(3021960) Folate [Moles/volume] in Serum or Plasma

5240

11962

2.60

307.65

1.7

1.4

19.53

19.73

nmol/l

0.44

4664

10457

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2416

4394

2.99

307.65

1.8

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2737

5765

2.59

307.65

1.8

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10249

27835

2.67

307.65

6.0

6.5

10.90

12.51

umol/l

16.84

9714

26377

(3017732) Neutrophils [#/volume] in Blood

2784

6000

2.53

307.65

3.0

2.8

4.66

4.18

e9/l

1.57

2499

5331

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3242

6413

2.82

307.65

1.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2862

5274

3.00

307.65

1.7

1.5

1161.02

1124.66

nmol/l

1.09

2230

3961

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5174

10444

2.98

307.65

2.2

1.7

0.98

1.36

mg/l

8.49

3825

7703

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

993

415

12.56

307.65

1.8

1.6

4868.47

718.06

e6/l

0.56

785

294

(3021589) Normoblasts [#/volume] in Blood

9107

29160

2.01

307.65

11.6

7.3

0.00

e9/l

0.38

7470

23337

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9571

22350

3.12

307.65

7.7

5.4

1.21

mmol/l

1.90

8371

19227

(3002032) Base excess in Venous blood by calculation

2018

3666

2.95

307.65

5.2

4.0

1.71

1.63

mmol/l

0.43

1753

3134

(3016502) Oxygen saturation in Arterial blood

1952

3358

3.12

307.65

9.9

8.9

95.99

96.38

1.43

1885

3233

(3018095) Leukocytes [#/volume] in Urine

7559

21230

2.23

307.65

4.2

2.8

59.37

84.19

e6/l

2.16

5361

12775

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15679

55627

2.67

307.65

4.8

3.2

14.53

14.35

pmol/l

16.39

14790

51117

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6703

15672

2.69

307.65

2.9

2.2

67.74

67.19

u/l

0.02

6280

14563

(3023368) Bacteria identified in Blood by Culture

5106

11458

2.64

307.65

4.3

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9296

30326

1.97

307.65

2.9

2.5

—

estimate

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8612

19561

3.06

307.65

7.3

5.4

1.21

mmol/l

1.14

8052

18075

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

979

413

12.44

307.65

1.7

1.5

21.29

10.91

e6/l

1.26

734

281

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19163

84005

2.76

307.65

12.2

6.6

28.19

25.79

u/l

39.79

18836

81411

(3019069) Monocytes/Leukocytes in Blood

9988

27584

2.57

307.65

7.3

5.0

8.48

8.59

3.51

9493

25945

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5447

13370

2.41

307.65

2.4

2.1

2.67

2.58

mg/l

2.13

4773

11482

(3013650) Neutrophils [#/volume] in Blood by Automated count

11782

35225

2.56

307.65

9.7

8.6

4.10

3.90

e9/l

13.96

10415

29984

(3007164) IgA [Mass/volume] in Serum or Plasma

5414

14521

2.18

307.65

1.5

1.4

2.17

2.11

g/l

1.79

3543

9615

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3680

7853

2.64

307.65

3.7

2.7

373.29

851.46

ng/l

5.76

2275

5136

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18790

75151

3.54

307.65

16.2

7.6

20.09

25.60

mg/l

91.68

15873

54405

(3020564) Creatinine [Moles/volume] in Serum or Plasma

19346

83070

3.30

307.65

18.6

9.0

73.26

72.46

umol/l

3.26

19206

81685

(3033658) Prothrombin time (PT) actual/Normal

5261

13783

2.23

307.65

4.7

3.7

92.71

92.00

1.22

5153

13502

(3026782) Osmolality of Urine

3943

9043

2.47

307.65

3.0

2.2

541.46

554.20

mosm/kgh2o

2.23

3507

7716

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3845

8556

2.54

307.65

1.7

1.4

37961444.05

26991170.94

pmol/l

0.46

3335

7447

(3019550) Sodium [Moles/volume] in Serum or Plasma

18615

71420

3.84

307.65

17.2

8.2

139.58

139.73

mmol/l

15.53

18347

69012

(3019977) pH of Arterial blood

2193

3851

3.08

307.65

9.5

8.3

7.41

7.42

2.46

1261

1753

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2716

3987

3.78

307.65

2.2

2.5

372.69

398.46

nmol/l

6.86

2559

3754

(3009508) Creatinine [Moles/volume] in Urine

6450

12542

3.29

307.65

3.8

1.9

8.35

8.65

mmol/l

3.30

5677

11109

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14511

45007

3.03

307.65

8.0

6.3

76.67

78.47

u/l

3.60

13918

42374

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2007

2806

3.87

307.65

2.4

2.2

20.23

20.66

au/ml

0.08

231

514

(3037467) Urinalysis macro (dipstick) panel - Urine

13421

44819

2.41

307.65

4.7

3.0

3.51

2.40

0.66

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

17476

69275

2.63

307.65

13.7

7.5

92.94

90.90

ml/min/173m2

27.58

16034

60064

(40768797) Stomach Pathology biopsy report

2771

5988

2.53

307.65

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

501

116

22.19

307.65

1.1

41.09

30.21

mg/l

2.72

415

(3020630) Protein [Mass/volume] in Serum or Plasma

1439

2020

3.77

307.65

2.5

2.9

67.30

65.96

g/l

6.27

1342

1888

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8270

26054

1.98

307.65

3.8

2.3

0.09

0.13

estimate

0.15

1962

5176

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

464

101

23.57

307.65

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

482

112

22.09

307.65

1.1

233.50

218.35

mg/l

0.44

424

(3020682) Albumin/Creatinine [Ratio] in Urine

5126

8136

3.87

307.65

4.5

2.1

10.95

9.56

mg/mmol

0.73

3411

4259

(3032080) INR in Blood by Coagulation assay

8448

18282

3.22

307.65

11.0

8.4

1.16

1.17

inr

1.14

7098

14999

(3005719) IgG [Mass/volume] in Serum or Plasma

2169

3083

3.83

307.65

2.7

2.5

10.38

10.66

g/l

1.79

2007

2876

(1002224) Polysomnography panel

1628

2725

3.17

306.92

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1816

3262

2.97

305.72

10.5

8.8

124.69

121.00

g/l

8.50

1778

3167

(3000475) Leukocytes [#/volume] in Synovial fluid

423

142

15.25

302.76

1.7

1.2

11526.10

13624.30

e6/l

0.12

298

(3015235) Bicarbonate [Moles/volume] in Capillary blood

802

762

5.46

299.57

2.7

2.8

24.51

24.43

mmol/l

0.16

791

738

(3011397) Hemoglobin [Presence] in Urine by Test strip

4825

13854

1.97

294.03

3.8

2.5

0.13

0.00

109

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

443

179

12.67

293.11

1.4

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3426

8687

2.17

287.91

3.0

2.3

0.95

1.11

e6/l

0.96

1761

3873

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1025

1283

4.17

286.14

5.2

6.5

24.48

24.30

mmol/l

1.02

971

1234

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

333

26.95

284.22

1.1

1.0

1.01

1.16

u/l

0.33

128

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

468

225

10.66

284.17

3.2

2.1

0.96

0.80

nmol/l

2.28

398

206

(3023410) Appearance of Cerebral spinal fluid

479

249

9.86

278.64

2.2

1.9

—

(3017181) Myelocytes/Leukocytes in Blood

1853

3563

2.77

276.38

4.7

4.1

0.82

0.93

0.71

512

1005

(3048689) Calprotectin [Mass/mass] in Stool

3609

9492

2.10

275.82

2.5

3.0

101.46

123.54

ug/g

3.75

2897

7655

(3014111) Lactate [Moles/volume] in Serum or Plasma

1849

3574

2.75

273.07

9.0

8.2

1.32

1.30

mmol/l

0.18

1814

3508

(3002179) Metamyelocytes/Leukocytes in Blood

1774

3369

2.80

270.27

4.5

4.0

0.59

0.72

1.23

484

971

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3372

8697

2.13

270.17

2.5

3.3

2.42

2.43

mmol/l

1.93

3019

7796

(3025159) Blasts/Leukocytes in Blood

1814

3490

2.76

270.04

5.0

4.3

0.07

0.54

1.83

407

842

(3020779) Urea [Moles/volume] in Serum or Plasma

1776

3377

2.79

269.97

9.6

6.1

8.03

7.39

mmol/l

3.22

1723

3259

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1635

2964

2.92

269.88

3.3

2.6

4.60

4.59

pmol/l

0.11

1496

2690

(3021440) Promyelocytes/Leukocytes in Blood

1780

3412

2.77

266.60

4.8

4.2

0.12

0.07

439

871

(3041096) Erythrocytes [Presence] in Urine by Automated

6259

20184

1.80

263.25

3.3

2.1

0.17

0.08

estimate

0.29

1931

5017

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1172

1747

3.51

260.93

8.1

5.8

24.42

24.45

mmol/l

0.07

1124

1644

(3019060) Gas panel - Arterial blood

1103

1576

3.65

260.19

6.0

4.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

376

143

13.43

255.51

2.6

2.0

151.61

120.71

ug/min

0.24

248

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

355

119

15.22

254.14

1.3

1.1

1.84

1.90

mmol/l

0.27

329

110

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1348

2275

3.11

249.45

2.4

1.8

7.11

10.95

ug/l

4.54

1199

2016

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1061

1521

3.64

248.99

2.0

2.2

39.00

41.75

u/l

3.36

984

1424

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

783

881

4.60

246.23

1.3

1.1

32.92

7.61

u/ml

1.41

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4858

14720

1.86

246.22

2.4

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

380

165

11.76

242.91

1.7

1.3

—

(3000991) Gas panel - Venous blood

1849

3800

2.58

242.41

10.7

8.7

—

(3014051) Protein [Presence] in Urine by Test strip

6069

19794

1.76

241.52

2.9

2.2

0.02

0.04

0.24

279

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1358

2351

3.03

241.09

4.5

3.6

81.35

72.47

ng/l

2.78

1225

2108

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

733

795

4.76

239.66

1.3

1.1

12.02

9.55

u/ml

0.19

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

450

279

8.25

234.94

1.1

2495.71

10.75

iu/ml

0.54

111

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

726

798

4.70

233.99

1.3

1.1

3.50

2.41

u/ml

0.66

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3189

8479

2.05

233.26

3.1

2.3

3.31

2.80

e6/l

1.42

1522

3655

(3045414) Leukocytes [Presence] in Urine

1927

4134

2.48

231.57

2.0

1.7

0.03

0.06

estimate

1.37

438

1074

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16432

70711

1.78

226.29

4.1

2.9

1.32

1.16

mmol/l

135.32

15593

67127

(3009445) Proteinase 3 Ab [Units/volume] in Serum

898

1225

3.80

224.64

1.5

1.3

9.99

5.92

iu/ml

0.51

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2021

4510

2.38

223.34

5.9

4.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1591

3169

2.65

220.66

10.6

9.2

24.70

24.65

mmol/l

0.22

1580

3151

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17491

76930

1.87

219.53

5.2

3.5

2.76

2.92

mmol/l

109.80

16696

73129

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3707

10642

1.91

217.58

2.0

1.6

1.46

1.29

34.19

3308

9772

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7623

27079

1.65

217.23

1.9

1.6

1.46

1.26

mmol/l

48.17

6669

24077

(3004119) Hemoglobin [Mass/volume] in Venous blood

1197

2050

3.05

215.69

4.0

3.4

132.93

131.49

g/l

1.08

1168

2004

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1843

4007

2.44

214.78

3.3

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1443

2779

2.73

212.74

1.9

1.6

0.30

0.25

mg/l

2.39

686

1231

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

16195

69805

1.73

212.19

19.3

10.1

13.39

13.27

32.88

16055

68444

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17373

76465

1.84

211.86

4.8

3.3

4.61

4.83

mmol/l

165.85

16656

73050

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1369

2569

2.79

211.38

5.6

4.5

24.20

24.16

mmol/l

0.19

1357

2549

(3027945) Reticulocytes/Erythrocytes in Blood

1973

4474

2.34

210.02

3.2

2.8

1.75

1.60

7.49

1783

4047

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1257

2267

2.90

207.81

11.4

10.7

1.38

1.23

5.44

1249

2260

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17280

76080

1.81

206.65

4.7

3.2

1.39

1.50

mmol/l

225.90

16496

72445

(3020891) Body temperature

883

1268

3.61

206.17

4.8

3.5

36.94

36.89

°c

2.14

872

1259

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1556

3183

2.57

204.58

2.7

1.9

0.36

0.37

e6/l

0.01

1477

3030

(3005322) IgE [Units/volume] in Serum or Plasma

1920

4373

2.33

202.06

1.4

1.3

234.94

311.56

u/ml

1.34

1791

4072

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1033

1689

3.18

199.91

3.9

3.3

1.43

1.24

4.08

1028

1681

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

806

1107

3.76

199.59

1.2

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

578

596

4.98

198.82

1.2

1.1

4.26

8.66

u/ml

0.23

(3014007) Fractional oxyhemoglobin in Arterial blood

1243

2291

2.83

197.74

11.6

10.8

94.13

94.81

2.69

1236

2286

(3009466) Valproate [Moles/volume] in Serum or Plasma

527

500

5.40

196.57

6.0

7.2

376.16

405.87

umol/l

3.26

472

432

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2504

6448

2.08

196.48

3.0

6.81

9.18

umol/l

5.76

2152

5693

(3019225) pH of Specimen

1661

3587

2.44

195.59

3.5

2.9

7.35

0.03

1238

2423

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1457

2952

2.59

194.86

3.7

3.1

1.23

mmol/l

0.66

1266

2469

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

869

1318

3.41

187.82

1.6

1.5

0.20

0.14

iu/ml

0.20

121

251

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

882

1353

3.37

187.54

4.3

3.0

51.44

47.32

3.63

866

1332

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1362

2742

2.60

184.11

1.8

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

626

748

4.30

183.66

1.2

1.1

47.28

45.77

u/ml

0.04

(3007461) Platelets [#/volume] in Blood

19823

92434

2.51

182.11

24.6

11.8

259.45

255.38

e9/l

15.58

19626

89703

(3023520) Reticulocytes [#/volume] in Blood

1455

3047

2.50

181.98

2.9

2.7

71.79

66.92

e9/l

3.90

1033

2098

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1143

2106

2.82

181.61

11.5

11.1

24.22

24.24

mmol/l

0.07

1127

2063

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

694

913

3.91

181.41

2.1

1.3

3.65

2.00

iu/l

3.47

310

294

(3035941) MCH [Entitic mass]

19826

92544

2.49

178.61

24.5

11.7

30.09

30.05

1.83

19731

91353

(3024731) MCV [Entitic mean volume] in Red Blood Cells

19825

92546

2.49

178.27

24.5

11.7

89.99

89.78

9.28

19731

91351

(36660697) Celiac disease serology panel - Serum

2231

5694

2.08

178.04

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

19826

92560

2.49

177.99

25.1

12.0

40.84

42.35

7.41

19726

91291

(3026361) Erythrocytes [#/volume] in Blood

19827

92573

2.49

177.75

24.5

11.7

4.58

4.59

e12/l

1.83

19608

89588

(3010813) Leukocytes [#/volume] in Blood

19829

92613

2.48

176.72

24.6

11.8

6.88

6.50

e9/l

73.64

19605

89590

(3000963) Hemoglobin [Mass/volume] in Blood

19828

92644

2.47

175.25

24.7

11.8

136.96

137.33

g/l

3.00

19734

91458

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1899

4578

2.19

174.31

2.4

2.7

0.22

g/l

1.62

1771

4342

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

215

21.80

173.88

1.4

1.2

1.47

1.71

nmol/l

0.55

197

(3017143) Hepatitis C virus Ab [Presence] in Serum

3626

11023

1.79

173.81

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

203

25.09

170.45

1.7

1.1

52.33

60.07

0.45

121

(1616796) Gas panel - Central venous blood

542

617

4.50

167.84

3.4

2.8

—

(3021901) Oxygen saturation in Capillary blood

473

5.11

167.64

2.7

2.4

91.07

90.93

0.14

459

460

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

223

17.14

167.12

1.4

1.2

72.56

86.60

—

(3018405) Lactate [Moles/volume] in Arterial blood

626

824

3.90

163.40

4.1

3.3

1.40

1.43

mmol/l

0.16

613

810

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

624

820

3.91

163.22

2.1

7.22

7.01

g/l

1.67

587

755

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

623

819

3.91

162.88

2.1

3.59

3.79

g/l

1.67

587

753

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

623

820

3.90

162.63

2.1

4.26

4.14

g/l

1.96

586

755

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2022

5139

2.08

162.30

4.4

4.8

235.45

251.67

u/l

2.05

1923

4962

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1103

2125

2.70

161.44

1.7

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

778

1218

3.29

160.29

5.8

6.5

8.92

9.08

kpa

1.24

758

1185

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

599

785

3.91

157.18

2.2

2.1

2.81

2.95

g/l

1.91

562

719

(3000494) Fungus identified in Specimen by Culture

2494

6931

1.92

156.43

1.6

1.3

—

(3010421) pH of Blood

697

1029

3.48

156.22

3.6

2.6

7.41

0.15

687

1012

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2169

5743

2.00

155.90

2.6

2.4

6372.45

7370.38

u/l

0.59

792

2583

(3045424) Erythrocytes [Presence] in Urine

1057

2039

2.69

154.21

2.1

1.7

0.74

0.11

estimate

0.42

351

869

(3027273) Bicarbonate [Moles/volume] in Venous blood

784

1270

3.18

153.37

3.8

2.6

25.15

25.20

mmol/l

0.12

758

1218

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1171

2412

2.52

150.65

3.3

2.6

145.81

180.67

ng/l

1.81

1022

2191

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

231

102

11.49

146.40

1.2

1.0

—

(3036489) Thrombin time

1058

2110

2.60

144.84

3.2

2.4

20.74

20.86

0.22

927

1848

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1079

2176

2.57

144.57

12.5

10.4

16.37

16.20

0.96

1040

2083

(4146454) Self-monitoring of blood glucose

180

20.71

143.48

2.8

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1483

3497

2.22

142.31

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1068

2160

2.56

142.26

3.3

2.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

800

1383

2.98

141.04

6.6

4.3

1.73

1.66

0.77

751

1279

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

539

708

3.90

140.96

2.4

2.3

0.57

1.07

g/l

1.62

487

616

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

192

15.19

137.71

1.5

1.0

5.88

5.07

u/l

0.64

163

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1366

3157

2.25

137.18

1.2

1.1

1.03

16.63

u/ml

1.05

(3023183) Ammonium ion [Moles/volume] in Plasma

542

732

3.79

136.81

3.0

2.9

33.86

37.25

umol/l

1.68

509

683

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

535

717

3.82

136.38

2.2

10.14

10.45

g/l

0.63

497

649

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1976

5297

1.96

136.29

1.3

1.2

128.14

151.66

u/ml

1.33

743

1997

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1991

5359

1.96

135.74

2.7

2.3

59.93

48.07

u/l

0.20

1679

4661

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

688

1110

3.18

135.27

2.1

1.8

1.73

2.40

ug/l

0.52

611

998

(40767503) Oxygen content in Capillary blood by calculation

484

604

4.10

134.77

2.4

1.8

17.30

17.09

0.57

472

593

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1085

2272

2.47

134.73

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

118

9.84

133.77

1.2

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

218

103

10.73

133.49

1.1

5.54

0.48

nmol/l

1.14

(3023511) Choriogonadotropin [Units/volume] in Urine

1148

2487

2.39

132.82

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

724

1258

2.96

126.44

7.1

4.6

0.88

0.90

0.64

681

1160

(3000570) Elastase.pancreatic [Mass/mass] in Stool

628

1003

3.21

125.33

1.4

1.3

310.58

293.10

ug/g

0.84

332

553

(3022145) Colonoscopy Study observation

2235

6421

1.84

124.99

1.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

205

10.60

124.77

1.7

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1458

3608

2.11

123.88

2.6

2.2

75.79

79.17

ml/min/173m2

1.92

602

1298

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

476

628

3.87

123.75

2.3

2.2

0.01

0.05

g/l

0.59

441

570

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

388

431

4.59

123.33

1.7

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

154

20.49

122.42

1.5

1.1

36.74

30.83

0.40

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

457

592

3.94

121.56

2.3

0.00

g/l

0.50

409

526

(3003129) Base excess in Capillary blood by calculation

250

172

7.37

121.46

1.9

2.0

0.38

0.78

mmol/l

0.61

244

149

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

126

53.03

121.15

2.7

2.3

29.38

26.80

umol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

621

1015

3.14

119.58

2.1

2.2

10.76

10.47

mg/l

0.43

584

973

(3012501) Base excess in Blood by calculation

484

670

3.69

118.25

3.7

2.8

2.19

2.39

mmol/l

0.69

297

401

(3013290) Carbon dioxide [Partial pressure] in Blood

484

670

3.69

118.25

3.7

2.8

5.00

4.92

kpa

1.19

474

653

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2058

5856

1.85

118.20

4.3

3.1

30.76

32.49

9.53

1567

3961

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

318

304

5.32

117.68

1.2

28.43

28.30

nmol/l

—

(3027315) Oxygen [Partial pressure] in Blood

483

673

3.67

116.98

3.7

2.8

9.17

8.98

kpa

1.03

473

656

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

576

930

3.17

113.01

1.2

1.3

3.56

3.61

iu/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

426

559

3.89

111.50

2.4

2.3

0.00

g/l

-0.00

408

526

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

12.61

110.80

1.2

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

545

860

3.24

110.70

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

326

341

4.86

110.40

1.2

1.1

49.37

27.65

u/ml

0.39

(3010144) Erythrocytes [#/volume] in Synovial fluid

159

13.86

109.98

1.3

1.0

167740.07

51020.36

e6/l

0.88

101

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

147

16.89

109.75

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

1806

5049

1.87

109.06

4.1

2.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

326

346

4.79

108.76

1.6

1.2

1.28

1.57

promille

1.79

254

274

(3004616) Nuclear Ab [Presence] in Serum

295

285

5.26

108.09

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

611

1055

2.97

107.71

7.7

4.7

1.24

1.26

mmol/l

0.19

534

923

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

164

12.02

106.44

1.1

1.0

198.24

116.53

ng/l

0.37

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

126

25.45

106.27

1.1

—

(3025941) Bacteria identified in Stool by Culture

1394

3622

2.00

103.68

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2346

7208

1.71

103.67

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

586

1013

2.96

103.09

1.7

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

509

805

3.23

103.02

1.3

1.2

4.33

3.52

u/ml

0.54

236

389

(3009214) Lutropin [Units/volume] in Serum or Plasma

1268

3195

2.06

102.30

1.6

1.5

7.95

8.46

u/l

0.78

1012

2461

(3034860) Kappa light chains.free [Mass/volume] in Serum

429

607

3.60

101.77

3.1

3.8

43.47

47.10

mg/l

0.32

363

539

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

428

605

3.61

101.67

3.1

3.8

39.31

37.20

mg/l

0.12

360

537

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

363

454

4.07

100.79

1.2

1.0

418.10

169.84

titre

0.79

(40768804) Tissue Pathology biopsy report

7089

27972

1.41

100.70

2.0

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

601

1074

2.86

99.97

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

581

1025

2.90

98.78

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

523

869

3.07

98.07

1.3

1.2

4.05

1.91

u/ml

2.18

199

308

(3011288) Drugs identified in Urine by Screen method Nominal

1604

4476

1.87

96.93

3.6

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

759

1576

2.47

95.43

1.9

1.8

1.46

1.32

g/l

3.24

675

1357

(3013139) Helicobacter pylori Ag [Presence] in Stool

1495

4117

1.89

93.91

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

360

474

3.86

93.83

1.9

1.5

1.73

1.80

mmol/l

0.39

353

465

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2147

6619

1.70

93.10

2.6

1.9

12.14

13.49

nmol/l

9.87

1964

6199

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

383

539

3.62

91.53

3.1

3.7

2.09

4.31

ratio

0.78

212

311

(3024928) Oxygen saturation in Venous blood

552

992

2.84

90.91

4.3

4.4

62.33

64.19

0.95

535

974

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

896

2061

2.24

90.20

4.6

3.0

96.19

91.12

8.13

871

1983

(3020961) Endomysium IgA Ab [Titer] in Serum

1391

3790

1.90

90.06

1.2

1.1

295.20

207.36

titre

0.34

151

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

799

1751

2.34

89.65

1.2

4.38

4.11

0.29

112

357

(3006184) Hemoglobin [Mass/volume] in Capillary blood

507

880

2.94

88.56

2.2

1.9

134.17

133.03

g/l

0.44

423

741

(3021387) Prolactin [Units/volume] in Serum or Plasma

1569

4483

1.82

87.77

1.7

1.6

309.10

315.38

mu/l

0.21

1437

4003

(3027923) C peptide [Moles/volume] in Serum or Plasma

136

11.84

87.74

1.9

3.4

1.37

1.32

nmol/l

0.11

105

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

16.24

87.67

1.1

1.0

—

(4195642) Thrombophilia screening test

481

815

3.01

87.40

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

545

997

2.79

87.01

2.8

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

550

1016

2.76

86.31

6.3

4.6

0.35

0.32

iu/ml

0.77

296

508

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

17.07

86.26

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

250

257

4.93

86.23

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

521

935

2.84

86.00

1.5

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

139

10.80

85.65

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1315

3577

1.90

85.43

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

836

1910

2.25

85.42

3.7

2.6

167.83

179.27

2.98

804

1820

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

607

1193

2.60

84.97

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4682

17561

1.44

84.85

2.5

2.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

386

582

3.37

83.82

2.5

3.5

22.12

22.16

nmol/l

0.02

368

563

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

562

1068

2.69

83.78

1.7

355.93

440.66

mu/l

1.81

458

853

(3007566) Smooth muscle Ab [Titer] in Serum

704

1503

2.40

83.48

1.2

1.5

75.11

104.13

titre

1.15

138

(3034770) Mitochondria Ab [Titer] in Serum

689

1456

2.42

83.47

1.2

1.4

647.00

1151.67

titre

1.26

(3006653) Thiamine [Moles/volume] in Blood

151

8.87

83.25

1.4

133.22

129.75

nmol/l

0.23

151

(1001926) Buprenorphine [Presence] in Urine by Screen method

1747

5239

1.74

83.05

2.8

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

473

820

2.94

82.78

1.1

114.17

112.60

0.45

437

725

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

348

493

3.59

82.44

1.3

1.4

0.38

0.14

nmol/l

0.66

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

115

14.88

81.98

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

582

1146

2.59

81.17

2.9

2.7

2.38

2.84

index

0.42

322

607

(3024980) IgG subclass 4 [Mass/volume] in Serum

461

798

2.94

80.88

1.6

0.70

0.80

g/l

0.97

359

634

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

15.01

80.83

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

6465

25886

1.37

79.10

2.3

2.2

—

(3003181) Sodium [Moles/volume] in Urine

341

492

3.52

78.80

1.5

1.7

66.96

65.35

mmol/l

0.19

296

371

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5010

19245

1.40

78.46

2.6

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

494

907

2.78

78.36

1.1

—

(3022621) pH of Urine by Test strip

1626

4855

1.74

78.27

2.4

1.9

6.16

6.24

2.60

1032

2912

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

15.88

78.21

1.1

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

232

244

4.82

78.21

1.1

—

(4268621) Lupus anticoagulant assay

373

577

3.29

78.04

2.5

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

299

395

3.84

77.64

7.6

6.5

10.50

10.53

mg/l

0.03

274

374

(3008295) Osmolality of Serum or Plasma

279

353

4.01

76.45

1.6

2.0

284.12

279.92

mosm/kgh2o

1.59

214

288

(3024139) IgG subclass 3 [Mass/volume] in Serum

310

427

3.69

76.27

1.4

1.2

0.39

0.38

g/l

0.23

219

304

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

8.99

76.17

1.1

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

310

428

3.68

76.04

1.4

1.2

2.92

3.02

g/l

0.35

220

306

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

965

2453

2.02

75.61

1.7

9.14

12.18

u/ml

1.52

255

859

(3027135) IgG subclass 1 [Mass/volume] in Serum

310

430

3.66

75.57

1.4

1.2

6.44

6.64

g/l

0.36

221

305

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

410

690

3.02

75.33

1.5

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

772

1799

2.20

75.25

2.2

1.6

199.55

217.60

pmol/l

3.44

743

1743

(3014148) Varicella zoster virus Ab [Titer] in Serum

573

1164

2.51

75.19

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

225

239

4.77

75.09

1.1

—

(4062490) Immunoglobulin typing, IgG

306

425

3.65

74.47

1.4

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1367

3941

1.79

73.88

2.3

1.7

—

(3035715) Granulocytes [#/volume] in Blood

435

770

2.88

73.52

3.4

3.3

4.03

3.84

e9/l

0.94

435

770

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

223

240

4.70

73.41

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

223

241

4.69

73.09

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

333

501

3.38

72.57

1.3

1.4

0.55

0.57

nmol/l

0.25

324

481

(3018572) Chloride [Moles/volume] in Blood

402

685

2.98

72.39

10.0

6.1

105.53

105.12

mmol/l

0.76

363

600

(3039000) Anion gap in Blood by calculation

401

685

2.98

71.92

10.0

6.1

11.46

11.13

mmol/l

0.93

362

600

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4160

15672

1.42

71.69

4.4

4.6

2.00

3.30

ug/l

2.81

3777

14476

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1028

2729

1.94

71.39

2.1

1.6

36.03

43.29

nmol/l

16.48

1006

2700

(3011412) CD3 cells [#/volume] in Blood

298

419

3.61

71.36

3.1

2.1

1385.39

1323.14

e6/l

0.37

246

319

(3037121) Protein [Mass/volume] in Urine

710

1639

2.22

70.72

3.4

3.8

366.10

255.44

mg/l

1.20

326

906

(3038026) Centromere Ab [Units/volume] in Serum

160

125

6.47

70.72

1.2

1.1

41.88

29.63

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

293

410

3.62

70.62

1.3

1.4

0.16

0.18

nmol/l

1.94

224

332

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

103

7.21

70.60

2.5

1.8

15.27

13.97

umol/l

0.48

147

103

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

16126

74611

1.37

70.45

20.0

9.9

333.68

333.71

g/l

0.14

16050

73987

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

217

237

4.64

70.35

1.2

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

549

1131

2.48

70.04

3.2

3.0

57.31

57.10

0.13

549

1131

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

194

192

5.11

69.56

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

381

645

3.00

69.35

1.8

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

115

10.18

68.75

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

212

232

4.62

68.59

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

738

1757

2.15

68.28

7.2

5.3

1.35

1.13

mg/l

12.87

702

1666

(3037756) Immunofixation for Serum or Plasma

278

384

3.67

68.18

1.5

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5175

20379

1.37

67.99

1.8

—

(3045716) Anion gap in Serum or Plasma by calculation

222

258

4.36

67.25

3.0

2.9

10.31

10.15

mmol/l

0.23

215

253

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

514

1048

2.50

66.95

6.9

4.3

613.12

472.02

iu/ml

0.24

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

417

768

2.76

65.80

3.7

3.5

1389.33

1073.73

u/ml

0.10

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

173

162

5.40

65.42

4.0

2.4

192.26

137.63

umol/l

0.96

(3018333) Ribosomal P Ab [Presence] in Serum

207

232

4.51

65.29

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

420

781

2.74

65.14

1.4

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

729

1764

2.11

64.77

1.3

39.20

49.48

u/ml

0.46

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

699

1664

2.15

64.66

1.3

238.46

222.71

u/ml

0.76

436

1068

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

270

383

3.57

63.93

1.6

1.7

—

(3011985) Renin [Units/volume] in Plasma

346

581

3.02

63.84

1.6

1.8

76.35

72.56

mu/l

0.06

321

538

(3016879) Cocaine [Presence] in Urine

1955

6448

1.58

63.78

2.7

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

328

537

3.10

63.01

1.5

357.56

400.93

pmol/l

0.59

287

475

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

714

1734

2.11

62.85

1.9

1.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

355

612

2.95

62.75

1.1

95.06

94.67

0.08

340

566

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

316

511

3.14

61.89

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

661

1566

2.16

61.86

1.8

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

303

481

3.19

61.05

1.7

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

810

2094

1.98

60.48

4.4

2.7

3.41

3.50

g/l

0.96

772

2002

(3004775) Volume in Urine collected for unspecified duration

109

8.87

60.22

2.4

1.8

611.23

755.89

1.58

(4024509) Urine culture

832

2183

1.95

59.60

1.9

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

268

399

3.40

59.35

1.8

1.5

91.52

90.70

1.67

263

394

(3008037) Lactate [Moles/volume] in Venous blood

377

696

2.75

59.26

3.1

2.2

1.48

1.42

mmol/l

0.44

363

678

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

111

8.12

57.98

1.0

279.45

266.38

ng/l

0.13

(3000764) Benzodiazepines [Presence] in Urine

2053

6993

1.53

57.82

2.7

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

256

376

3.45

57.81

5.2

2.0

6.95

5.89

mmol/l

5.13

222

295

(3016244) Insulin [Units/volume] in Serum or Plasma

300

492

3.09

57.51

3.6

3.2

29.80

22.27

mu/l

2.00

285

464

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

110

8.04

57.12

1.0

39.95

28.41

ng/l

1.63

(3023419) Bacteria identified in Sputum by Culture

237

332

3.61

57.12

3.2

2.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

247

357

3.50

57.04

3.2

2.3

229.26

235.41

e6/l

0.14

198

255

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

240

341

3.56

56.74

3.2

2.2

549.96

556.27

e6/l

0.04

182

237

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

309

521

3.01

56.68

1.7

1.4

—

(3003694) ABO and Rh group [Type] in Blood

6452

26798

1.30

56.64

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1525

4871

1.62

56.48

1.1

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

193

232

4.21

56.32

2.4

2.3

1.71

0.94

g/24h

1.54

118

128

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

634

1536

2.11

56.13

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

2059

7070

1.51

55.76

2.7

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

323

566

2.89

55.60

1.3

1.2

28.75

33.91

u/l

0.24

280

502

(3027008) Opiates [Presence] in Urine

2052

7054

1.51

55.25

2.5

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1717

5675

1.57

55.14

1.5

1.4

18.62

23.55

iu/l

8.87

1443

4703

(1175426) CD3 cells/Lymphocytes in Blood

247

367

3.41

54.89

3.0

1.8

74.30

70.00

2.97

237

359

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

108

7.78

54.87

1.0

768.04

889.91

ng/l

0.85

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

632

1552

2.08

54.07

1.4

16.27

19.90

u/ml

—

(3044927) Protein electrophoresis panel - Urine

134

117

5.78

54.05

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

214

292

3.71

53.43

1.8

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

414

849

2.48

53.34

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

414

849

2.48

53.34

1.4

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

171

194

4.45

53.30

1.2

1.1

19.72

6.93

u/ml

0.44

(4198724) Urine methamphetamine measurement

270

435

3.14

53.24

4.0

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

531

1224

2.21

53.05

1.4

1.3

19.09

23.48

u/l

2.31

445

1028

(3027944) Amphetamines [Presence] in Urine

2019

6994

1.50

52.26

2.6

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

238

357

3.37

52.20

2.9

1.9

—

(44806118) Parainfluenza type 4 nucleic acid detection

332

615

2.74

51.91

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

332

615

2.74

51.91

1.7

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

239

361

3.35

51.90

2.9

1.8

12.20

12.62

0.29

233

352

(44790047) Parainfluenza type 1 nucleic acid detection

332

616

2.73

51.76

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

332

616

2.73

51.76

1.7

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3214

12190

1.38

51.06

2.4

2.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

165

190

4.39

50.61

1.6

3.84

3.01

nmol/l

0.18

127

154

(3000330) Specific gravity of Urine by Test strip

811

2231

1.86

50.50

3.1

2.4

1.02

ratio

1.16

724

1943

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

20.81

49.62

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

17.23

48.99

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

17.23

48.99

1.1

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

227

350

3.28

47.87

1.7

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

593

1490

2.03

47.79

1.5

1.4

131.80

141.47

au/ml

0.86

166

439

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.53

47.54

1.1

1.0

—

(3016750) Collection duration of Urine

7.86

47.12

2.3

1.8

504.49

509.98

min

0.14

(3024263) Appearance of Synovial fluid

8.67

46.94

2.2

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2725

10193

1.39

46.61

2.2

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

487

1145

2.16

46.44

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

241

396

3.08

46.14

1.1

292.56

287.48

mg/l

0.34

219

378

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

9.28

46.06

2.0

1.1

135.61

7.12

ug/min

1.15

(40768443) Skin Pathology biopsy report

847

2441

1.77

45.44

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

363

761

2.42

44.76

1.8

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

258

452

2.89

44.52

12.1

12.9

0.59

0.62

mmol/l

1.26

236

421

(4034850) Laboratory test

589

1516

1.98

44.48

9.3

5.7

—

(40768446) Kidney Pathology biopsy report

106

5.87

43.47

1.8

2.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

609

1602

1.94

43.26

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

142

165

4.34

43.18

3.5

1.8

56.99

65.92

mg/l

0.14

106

105

(42529406) Shigella sp [Presence] in Stool by Culture

612

1617

1.93

42.93

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

463

1103

2.13

42.78

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

293

568

2.61

42.22

3.3

2.3

7.11

6.29

mmol/l

6.15

285

556

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

545

1390

1.99

42.21

1.1

15.28

15.67

au/ml

0.05

127

465

(3010838) Calcium [Moles/time] in 24 hour Urine

321

653

2.49

42.11

2.1

2.0

5.14

5.82

mmol/24h

2.46

287

600

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

605

1604

1.92

42.03

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

125

134

4.71

41.51

1.1

4.44

2.83

iu/ml

1.78

(40757494) Bilirubin.total [Moles/volume] in Blood

118

120

4.96

41.36

2.6

2.3

65.87

120.19

umol/l

1.73

(3006245) CD3-CD19+ cells/cells in Blood

180

263

3.46

41.08

3.3

1.9

10.88

15.60

2.80

173

253

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.87

41.02

1.4

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

133

153

4.39

40.93

44.9

42.1

7.57

7.10

ug/l

1.48

121

133

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

202

322

3.17

40.60

1.1

1.05

1.06

ratio

0.38

171

266

(3036071) Salmonella sp Ab [Titer] in Serum

6.74

39.98

1.1

—

(3042517) Benzodiazepines panel - Urine

6.74

39.98

2.7

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

255

476

2.71

39.44

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

197

315

3.16

39.42

3.4

3.0

0.86

0.80

nmol/l

0.65

162

242

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

736

2123

1.77

39.35

1.1

3.66

5.94

eliau/ml

1.08

102

406

(3000060) B lymphocytes [#/volume] in Blood

156

212

3.71

39.28

3.1

1.9

0.22

0.62

e9/l

1.22

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

348

764

2.31

38.93

1.1

1.46

g/l

0.02

323

723

(3019420) Tryptase [Mass/volume] in Serum or Plasma

201

332

3.06

38.26

1.3

1.8

5.68

7.27

ug/l

2.03

180

303

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

201

332

3.06

38.26

3.1

2.4

0.78

0.74

e9/l

0.39

192

327

(3020911) Cortisol [Moles/time] in 24 hour Urine

120

134

4.52

38.19

1.4

92.30

237.63

nmol/24h

0.51

120

134

(3024891) Influenza virus A+B Ag [Presence] in Specimen

758

2237

1.73

37.48

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

11.95

37.10

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

11.95

37.10

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

11.95

37.10

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

11.95

37.10

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

159

229

3.51

37.07

1.5

1.3

—

(3004451) EKG impression Narrative

102

5.04

36.40

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

494

1292

1.94

35.71

1.9

2.5

11.13

9.06

titre

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

145

201

3.64

35.62

1.8

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3189

12706

1.31

35.17

3.8

3.7

21.23

21.27

0.04

1238

5519

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

332

751

2.24

34.77

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

424

1066

2.02

34.19

1.7

2.1

4749.09

2911.25

titre

0.31

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

5.63

34.07

1.4

1.3

129.37

105.81

nmol/l

0.47

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

356

837

2.16

34.04

1.2

1.33

1.26

0.05

(3017569) Oxygen content in Arterial blood

103

4.84

33.99

2.0

2.2

16.65

15.83

0.96

103

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

241

474

2.57

33.88

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

238

467

2.58

33.61

1.5

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.04

33.58

1.5

1.7

0.91

1.10

nmol/l

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

14.78

33.52

1.5

1.0

39.40

47.90

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

202

364

2.80

33.34

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

131

177

3.73

33.31

2.1

2.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.79

33.21

3.2

2.3

0.90

1.11

mmol/l

0.25

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

236

466

2.56

32.94

1.5

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

4.93

32.89

1.2

1.3

0.06

0.62

g/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

370

2.77

32.85

1.2

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

14.46

32.53

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

119

152

3.95

32.49

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

397

994

2.02

32.39

1.1

3.22

2.85

0.14

215

(3026389) Candida sp identified in Specimen by Organism specific culture

357

858

2.11

32.36

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

15.09

32.36

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.28

32.18

3.3

2.07

1.46

ratio

3.49

(3005988) Vibrio sp identified in Specimen by Organism specific culture

229

452

2.56

32.00

1.5

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

17.61

31.92

1.2

1.0

38.58

35.44

g/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

196

3.50

31.75

1.4

1.3

169.18

165.14

mmol/24h

0.17

136

196

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

228

451

2.56

31.73

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

757

2340

1.65

31.60

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

209

396

2.67

31.56

2.0

1.6

23.09

33.08

mg/l

1.56

146

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.93

31.48

2.6

2.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

227

450

2.55

31.46

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

14.76

31.37

1.1

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

171

290

2.98

31.29

1.8

1.6

131.73

127.02

0.33

165

279

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

338

807

2.12

31.17

3.7

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

104

123

4.26

31.13

1.9

1.7

8.02

6.90

mmol/l

2.27

104

123

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

153

243

3.18

31.05

2.4

3.1

28.13

26.60

umol/l

0.72

144

228

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

156

252

3.12

30.85

2.6

3.7

1.07

1.38

ug/l

1.12

144

246

(3002256) Pathology report gross observation

2270

8770

1.34

30.75

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

176

308

2.89

30.59

2.3

2.7

1.81

1.72

umol/l

0.79

161

286

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

222

442

2.54

30.53

1.5

1.4

11.36

11.14

umol/l

0.17

209

415

(21494814) CD8 cells/Lymphocytes in Specimen

110

4.44

30.44

2.5

1.7

28.76

32.01

1.01

110

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

189

3.47

30.01

1.5

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

121

167

3.65

29.98

25.3

25.7

112.65

148.25

ug/l

2.48

152

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

172

302

2.88

29.74

2.4

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

353

874

2.05

29.70

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

10.50

29.33

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

416

1101

1.92

29.14

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

16.35

28.89

1.1

—

(3034426) Prothrombin time (PT)

111

148

3.78

28.78

1.3

1.2

28.57

27.84

0.53

111

148

(3004809) Band form neutrophils/Leukocytes in Blood

266

594

2.26

28.77

3.5

3.2

1.38

1.99

1.27

246

529

(3042733) HLA Ab [Presence] in Serum

118

4.18

28.77

4.7

3.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

267

598

2.26

28.69

1.4

1.3

6.12

6.14

umol/l

0.03

237

547

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

13.75

28.41

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

207

413

2.53

28.39

3.1

3.5

96.62

95.26

0.21

197

384

(3007463) Buprenorphine [Presence] in Urine

14.37

28.23

4.9

7.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

108

144

3.78

28.01

1.5

1.3

13.87

13.32

pmol/l

0.58

124

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

156

268

2.94

28.00

3.1

1.9

27.20

27.33

0.04

151

260

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

171

3.51

27.95

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

123

182

3.41

27.74

1.5

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

181

341

2.68

27.68

1.8

1.5

20.32

26.15

umol/l

1.67

167

322

(3024869) Neuronal Ab [Presence] in Serum

12.89

27.65

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

479

1351

1.80

27.64

1.1

—

(3042631) Mycobacterium sp identified in Specimen

192

375

2.59

27.46

2.9

2.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

189

367

2.60

27.33

3.8

3.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

14.70

27.06

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

31.65

26.80

1.3

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1319

4777

1.41

26.45

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

957

3261

1.50

26.33

1.4

—

(3016038) Potassium [Moles/volume] in Urine

131

211

3.13

26.10

1.3

1.7

34.99

37.65

mmol/l

0.49

125

196

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1174

4174

1.44

26.05

1.4

1.3

234.50

233.75

miu/ml

0.02

530

2155

(3017315) Amylase [Enzymatic activity/volume] in Urine

124

193

3.24

26.02

1.3

1.1

398.50

274.23

u/l

0.61

113

182

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.63

25.97

1.2

24.60

—

u/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

141

239

2.98

25.91

1.1

94.64

89.36

1.18

112

173

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

157

285

2.78

25.70

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

157

285

2.78

25.70

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

157

285

2.78

25.70

1.5

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

808

2670

1.54

25.62

1.1

2.32

2.89

u/ml

0.76

464

1507

(3049717) Cytology report of Urine Cyto stain

473

1363

1.76

25.46

2.4

2.8

—

(3000012) Reticulocyte production index

203

425

2.41

25.32

2.1

2.2

0.87

0.85

0.25

127

258

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

139

237

2.96

25.31

1.2

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

131

217

3.04

25.00

1.7

1.6

148.89

140.87

0.45

125

198

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

210

450

2.36

24.95

1.4

1.3

1.66

5.56

u/ml

4.34

116

273

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

237

550

2.18

23.55

1.3

1.4

85.49

79.37

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

152

285

2.69

23.53

4.0

3.8

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

197

422

2.36

23.45

1.1

1.3

58.57

290.00

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

5.20

23.33

1.4

1.9

41.69

41.47

g/l

0.08

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.20

23.32

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

197

424

2.35

23.22

1.1

1.3

173.46

216.94

titre

0.23

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

187

395

2.39

22.95

1.4

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.06

22.73

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

180

378

2.40

22.37

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.26

21.72

5.2

1.6

4.86

4.66

kpa

0.83

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.26

21.72

5.2

1.6

11.21

10.90

kpa

0.34

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

151

3.30

21.49

1.3

96.79

83.16

3.21

151

(3042111) Morphology [Interpretation] in Bone marrow Narrative

246

602

2.06

21.48

1.8

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

194

2.99

21.39

1.3

1.2

0.28

g/l

0.03

148

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

118

203

2.93

21.26

1.1

91.15

95.85

0.69

(3000093) Morphology [Interpretation] in Blood Narrative

184

403

2.30

20.93

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

3.32

20.82

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

7.64

20.76

1.1

1.0

0.02

0.07

u/ml

0.74

(3028433) Virus identified in Specimen by Culture

122

3.55

20.68

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

140

3.35

20.59

1.4

1.3

—

(3033099) Centromere Ab [Titer] in Serum

5.57

20.56

1.1

—

(3017704) Immunofixation for Urine

4.11

20.54

1.4

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

210

493

2.15

20.37

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

118

209

2.85

20.27

1.2

1.3

108.94

106.98

0.16

109

192

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

172

371

2.34

20.25

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

214

508

2.13

20.20

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

3.30

20.19

1.6

1.5

46135.00

2834.73

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

194

2.91

19.98

1.1

91.31

95.80

0.44

(3028717) Thiamine [Mass/volume] in Blood

5.73

19.89

1.3

66.35

71.09

ug/l

0.37

(3003888) Timothy IgE Ab [Units/volume] in Serum

705

2392

1.50

19.83

1.1

5.79

6.71

u/ml

0.69

394

1426

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

20.11

19.82

1.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

874

3098

1.43

19.70

1.5

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.93

19.24

4.7

7.1

2.33

1.71

mg/l

1.06

(3001186) Copper [Moles/volume] in Serum or Plasma

139

3.26

19.23

1.4

1.2

16.47

16.59

umol/l

0.07

120

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

999

3644

1.40

19.19

1.8

1.5

4.82

3.12

mg/l

2.32

794

2204

(3008401) Mugwort IgE Ab [Units/volume] in Serum

676

2292

1.50

19.09

1.1

0.84

1.23

u/ml

1.35

331

1173

(3014271) Vancomycin [Susceptibility]

4.39

19.05

2.5

2.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

164

358

2.31

18.85

2.9

3.6

54.04

54.61

0.10

148

302

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

107

187

2.88

18.84

1.3

1.2

106.15

106.33

0.02

173

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

166

3.00

18.66

1.3

1.2

538.00

866.25

titre

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

123

234

2.65

18.65

2.3

2.9

85.70

623.62

ug/l

0.66

113

221

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3790

16405

1.20

18.59

1.6

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

228

578

1.99

18.22

1.3

1.7

—

titre

—

(3018133) Calcium [Moles/volume] in Urine

129

3.28

18.13

2.4

2.88

2.36

mmol/l

1.22

120

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

161

3.00

18.10

1.3

1.2

60.00

190.71

titre

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

188

444

2.14

18.03

1.1

107.65

125.24

pmol/l

3.55

188

444

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

192

2.81

18.03

1.4

1.5

21.29

25.25

u/ml

0.33

(3035320) C reactive protein [Mass/volume] in Body fluid

176

405

2.19

17.97

2.6

2.1

24.10

28.26

mg/l

0.66

120

267

(3038177) Helicobacter pylori Ab [Presence] in Serum

438

1369

1.62

17.66

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

157

349

2.27

17.38

1.3

1.1

8.20

8.07

mm/h

0.06

157

349

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

8.66

17.04

8.5

7.1

6.52

5.87

mmol/l

0.30

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

596

2021

1.49

16.87

1.6

1.5

0.43

0.46

nmol/l

0.22

456

1631

(3022493) Free Hemoglobin [Mass/volume] in Plasma

111

214

2.61

16.48

8.4

4.1

70.83

2879.79

mg/l

1.08

144

(3010726) Horse dander IgE Ab [Units/volume] in Serum

676

2371

1.45

16.16

1.1

1.77

2.66

u/ml

1.59

376

1311

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

101

187

2.72

16.16

2.4

2.7

8.87

10.23

mg/l

1.44

169

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

9.38

16.14

1.8

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

510

1689

1.53

16.13

1.1

0.38

0.55

u/ml

0.34

186

520

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

3.42

16.11

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

3.42

16.11

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

107

205

2.63

16.09

1.2

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

305

890

1.73

15.91

4.2

2.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.92

15.91

1.6

1.3

14.14

25.35

nmol/l

1.50

(21494755) Public health laboratory ask at order entry panel

2288

13671

0.82

15.77

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.48

15.73

1.1

1.0

0.69

0.67

umol/24h

0.10

(3014133) Dog dander IgE Ab [Units/volume] in Serum

596

2053

1.47

15.64

1.1

5.30

4.18

u/ml

0.41

325

1140

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

137

3.01

15.62

1.3

1.1

102.18

101.74

0.04

128

(3016273) Islet cell 512 Ab [Units/volume] in Serum

8.80

15.55

1.0

—

(3006270) Folate [Moles/volume] in Blood

138

305

2.28

15.53

1.1

398.19

408.94

nmol/l

0.23

129

291

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1950

11809

0.81

15.35

1.6

1.5

3.41

3.48

mmol/l

1.78

1287

7589

(3024932) HLA-DR beta [Type]

142

2.94

15.23

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.61

15.14

1.5

9.14

9.40

ug/l

0.14

(21494434) Karyotype in Bone marrow

139

312

2.25

15.12

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2555

15054

0.83

15.12

1.8

1.7

3.62

3.41

ratio

10.47

1873

10901

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

4.39

15.08

1.9

1.7

479493.66

136963.66

nmol/l

0.30

(3024471) HLA-A [Type]

147

2.88

14.86

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

128

3.03

14.81

1.2

1.1

77.89

81.96

0.35

(3045142) Bone marrow Pathology biopsy report

189

484

1.97

14.79

1.3

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.38

14.73

1.6

1.2

77.83

57.80

ng/l

0.13

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

140

319

2.21

14.73

2.8

2.6

44.44

38.05

3.35

130

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

160

2.77

14.59

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

940

3553

1.34

14.52

2.2

3.8

34.05

52.56

u/ml

2.21

902

3474

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

155

371

2.11

14.49

1.2

61.93

90.09

u/l

1.21

145

327

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.47

14.49

1.5

1.4

0.36

0.53

ug/l

0.98

(3051387) C reactive protein [Mass/volume] in Capillary blood

395

1267

1.58

14.42

3.7

2.3

23.03

28.12

mg/l

2.25

275

817

(37208534) Antinuclear antibody arbitrary concentration in serum

167

2.71

14.40

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.22

14.16

1.4

—

(44813793) Dust mix specific IgE antibody measurement

188

489

1.94

14.11

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

210

568

1.87

14.06

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

554

1923

1.46

14.03

1.1

6.32

u/ml

0.00

271

958

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.15

13.88

1.4

1.6

1.35

2.95

mg/l

1.17

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2373

10083

1.20

13.88

2.9

2.8

0.72

0.83

ug/l

4.22

1342

5503

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

8.17

13.80

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

119

260

2.31

13.80

1.1

1.0

9.68

16.50

u/ml

0.95

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.83

13.69

2.5

2.0

1.20

1.22

umol/l

0.09

(3045683) HLA typing for celiac disease panel - Blood or Tissue

191

508

1.90

13.47

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

134

2.85

13.32

1.2

1.1

71.56

75.30

0.18

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

115

3.02

13.27

1.2

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

2.39

3.34

mg/l

0.38

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

2.63

2.01

mg/l

0.22

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

2.75

2.37

mg/l

0.11

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

1.65

2.76

mg/l

0.51

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.06

13.26

1.3

1.4

1.17

1.19

mmol/l

0.45

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

1.11

0.76

mg/l

0.34

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

0.88

1.51

mg/l

0.56

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

1.07

1.21

mg/l

0.21

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

4.10

4.23

mg/l

0.03

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.06

13.26

1.4

1.6

3.16

3.17

mg/l

0.00

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

124

2.92

13.13

2.0

114.30

76.81

au/ml

0.25

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.66

12.97

1.4

1.5

317.22

326.98

pmol/l

0.06

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

15.71

12.96

1.0

1.1

—

(4035726) Immunohistochemistry procedure

1316

5301

1.26

12.70

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.35

12.70

2.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

3.23

12.58

1.7

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

164

425

1.94

12.50

3.0

3.2

15.21

14.28

index

0.29

114

281

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

2.76

12.40

3.7

2.2

1.11

1.26

0.32

137

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.80

12.39

1.2

1.0

1.68

1.30

umol/24h

1.41

(3006576) Bicarbonate [Moles/volume] in Blood

123

2.86

12.37

7.2

24.41

24.89

mmol/l

0.39

112

(3009871) Measles virus Ab [Titer] in Serum

104

225

2.33

12.37

1.7

1.6

3305.00

1835.56

titre

0.76

(3019174) dRVVT (LA screen)

5.18

12.33

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

759

5014

0.75

12.27

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

138

2.74

12.25

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

164

429

1.93

12.19

1.8

1.4

6.27

5.37

mmol/l

4.51

126

352

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.46

12.18

2.4

1.1

—

(3005033) Fetal Nuchal fold Thickness US

739

4893

0.75

12.15

1.5

1.25

1.26

0.22

527

3716

(3025018) Bordetella pertussis Ab [Titer] in Serum

206

583

1.78

12.05

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1283

5188

1.26

11.98

1.7

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.09

11.82

1.8

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

776

5084

0.76

11.82

1.6

—

(44806420) Estimation of glomerular filtration rate

249

751

1.67

11.69

2.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

194

2.39

11.59

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

194

2.39

11.59

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

194

2.39

11.59

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

194

2.39

11.59

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

360

1192

1.53

11.54

2.5

2.6

36.79

22.86

iu/ml

0.71

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

442

1529

1.46

11.48

1.4

122.97

123.85

pmol/l

0.01

425

1491

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

2.68

11.40

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

4.74

11.32

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.15

11.30

5.2

2.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.77

11.13

2.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

594

2189

1.37

10.87

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

592

2183

1.37

10.79

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

208

612

1.71

10.72

1.1

8.03

6.73

iu/ml

0.37

211

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

293

943

1.57

10.68

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

107

251

2.15

10.65

1.4

12.75

11.20

u/l

1.01

101

243

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

4.86

10.58

2.4

1.4

8.00

5.58

mmol/l

1.05

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.43

10.56

1.1

1.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

149

398

1.89

10.50

1.3

1.4

72.48

73.76

0.48

140

382

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

142

2.55

10.42

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

129

329

1.97

10.37

2.1

1.7

2.31

1.63

u/field

0.73

174

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

233

714

1.65

10.36

1.1

15.52

17.21

u/ml

0.33

314

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

136

354

1.94

10.33

1.1

1.0

12.60

14.37

u/ml

0.34

248

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

192

559

1.73

10.29

2.5

3.6

3.63

4.25

nmol/l

0.25

187

539

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.52

10.20

1.3

1.1

329.53

217.87

mg/l

0.24

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

141

2.53

10.15

1.8

2.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

145

389

1.88

10.10

1.3

1.4

497.90

627.20

mu/l

0.55

136

373

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

497

1801

1.39

10.08

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

224

2.18

10.05

2.0

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

224

2.18

10.05

2.0

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

110

2.74

9.94

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

199

2.25

9.94

1.5

1.6

5.77

5.73

u/l

0.01

160

(37021550) Renin [Units/volume] in Plasma --upright

3.28

9.91

1.4

1.8

215.13

68.94

mu/l

0.48

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

398

1390

1.45

9.91

1.1

3.04

2.82

eliau/ml

0.12

191

788

(3028679) Herpes simplex virus Ab [Presence] in Serum

195

577

1.70

9.89

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

18.08

9.88

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

197

2.25

9.81

1.2

1.1

23.95

16.77

u/l

0.75

178

(3001556) Androgen free Index in Serum or Plasma

111

2.72

9.79

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

474

1716

1.40

9.69

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

201

604

1.68

9.66

3.9

6.3

132.83

83.45

u/ml

0.41

223

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.60

9.64

1.2

1.0

8.81

8.19

u/l

0.09

(3051651) Icteric interference index of Serum or Plasma

114

286

2.01

9.62

3.2

3.7

0.78

0.95

index

0.73

114

280

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

139

2.50

9.61

1.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

139

2.50

9.61

1.8

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

4.12

9.49

1.7

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.28

9.48

1.2

1.48

1.60

iu/ml

0.15

(43055514) Macroprolactin [Presence] in Serum or Plasma

119

306

1.96

9.40

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.54

9.32

1.2

0.44

0.49

iu/ml

0.15

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

130

2.52

9.20

2.6

2.4

0.62

mmol/l

0.02

130

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

393

1.82

9.05

1.2

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

205

2.16

8.98

1.2

1.3

17.67

22.30

u/l

0.47

171

(3034274) Bile acid [Moles/volume] in Serum --fasting

571

2159

1.34

8.94

2.5

2.6

5.15

6.79

umol/l

2.73

427

1597

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

213

2.13

8.85

1.2

1.3

79.26

123.59

u/l

1.22

185

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.07

8.84

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

172

2.25

8.68

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

100

249

2.02

8.66

1.8

1.4

2.68

4.27

u/field

0.36

175

(44806071) Cardiolipin IgM antibody measurement

3.17

8.65

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.17

8.65

2.1

2.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.99

8.48

1.4

1.5

—

(1761868) Lipid panel - Serum or Plasma

7793

36878

1.10

8.47

2.8

2.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

121

2.49

8.40

1.0

0.02

0.28

u/ml

1.83

(3001964) Herpes simplex virus Ag [Presence] in Specimen

165

2.26

8.39

1.7

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

890

5496

0.80

8.36

1.1

0.64

0.62

ratio

0.44

516

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.67

8.27

1.1

4.89

5.78

u/ml

0.24

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.77

8.19

1.0

1.1

69.36

85.03

ug/l

1.83

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

530

2011

1.33

8.15

1.8

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.74

8.03

1.1

0.24

0.94

u/ml

1.58

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.57

8.00

1.2

1.0

308.80

397.73

u/ml

—

(40765096) Chromosome analysis panel by Banding

118

2.47

8.00

1.1

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

206

660

1.57

7.80

21.6

22.7

1442.15

2816.48

nmol/l

0.47

196

636

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.65

7.72

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

196

628

1.57

7.44

16.8

16.2

802.76

830.62

nmol/l

0.37

189

606

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

108

293

1.86

7.41

2.7

3.5

137.32

149.97

au/ml

0.08

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

979

5912

0.82

7.40

1.5

0.94

0.95

ratio

0.24

590

3581

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

979

5912

0.82

7.40

1.5

1.18

ratio

0.10

592

3606

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1962

11187

0.87

7.38

1.6

992.66

1054.95

mu/l

1.77

1653

9718

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.30

7.32

1.3

1.6

37.74

41.56

umol/l

0.23

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

978

5895

0.82

7.26

1.5

1.10

1.18

ratio

2.01

589

3564

(3001729) Color of Synovial fluid

14.07

7.22

1.2

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

961

5782

0.83

7.00

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

112

314

1.80

6.97

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.25

6.83

2.3

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.93

6.83

1.1

1.0

0.03

0.98

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.57

6.78

1.1

1.2

86.52

96.00

titre

0.27

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.67

6.77

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

171

545

1.58

6.69

1.8

2.1

3.50

2.64

u/ml

0.31

200

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1041

6189

0.84

6.67

1.5

60.49

63.64

ug/l

0.91

868

5240

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.77

6.64

1.6

1.5

527.79

255.24

nmol/l

1.35

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.46

6.64

1.3

60.03

60.58

0.03

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

128

380

1.70

6.59

2.5

2.4

155.37

148.45

nmol/l

0.31

112

328

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.77

6.53

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

135

409

1.66

6.46

1.3

1.2

6.21

5.37

mmol/l

3.70

126

380

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.12

6.45

1.2

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

155

488

1.60

6.40

1.5

1.3

32.41

36.04

g/l

2.41

140

447

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

162

2.08

6.38

1.0

1.2

0.97

6.34

u/ml

2.64

137

(3033942) Copper [Moles/time] in 24 hour Urine

4.55

6.33

1.1

1.7

0.18

0.92

umol/24h

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

110

317

1.75

6.30

1.3

1.2

425.40

668.92

u/l

0.85

102

308

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.76

6.28

1.3

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

143

2.15

6.27

1.0

1.1

1.61

4.60

u/ml

0.44

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

2.28

6.25

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

+∞

6.24

1.3

0.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.31

6.14

1.0

0.09

1.31

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

10.88

6.14

1.2

1.0

3.31

2.67

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.49

6.12

1.6

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

120

358

1.69

6.11

3.4

4.6

8.46

9.99

mg/l

1.54

307

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

553

3467

0.80

6.06

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.92

6.05

1.3

23.20

156.33

titre

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

2.14

5.98

5.2

3.6

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

390

1486

1.32

5.95

2.2

1.8

13.12

12.98

2.02

385

1460

(3023199) Leukocytes [#/volume] in Pleural fluid

145

458

1.59

5.94

1.4

2346.83

3549.37

e6/l

0.36

312

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

147

2.09

5.89

1.0

1.1

0.07

1.69

u/ml

1.28

(3045462) Protein/Creatinine [Ratio] in Urine

155

2.04

5.78

3.8

3.4

92.70

47.82

mg/mmol

0.50

141

(3019832) Treponema pallidum Ab [Presence] in Serum

4037

18809

1.10

5.71

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

7.81

5.66

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

+∞

5.46

1.1

0.0

1.26

—

mg/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.84

5.45

1.0

1.3

35.84

62.56

mg/l

1.86

(3052592) Norovirus Ag [Presence] in Stool

3.11

5.44

1.5

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

109

2.21

5.37

1.8

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.72

5.34

4.4

5.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

11.05

5.29

4.5

4.2

431.64

361.40

umol/l

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.73

5.27

3.4

2.1

15.84

17.82

mg/l

0.10

(40757373) Influenza virus identified in Isolate

2.48

5.26

1.8

1.3

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.82

5.24

1.0

0.04

0.37

u/ml

0.51

(3022725) Serotonin [Moles/volume] in Serum

4.71

5.20

1.5

1.1

961.67

1734.69

nmol/l

0.40

(3003843) Paprika IgE Ab [Units/volume] in Serum

4.71

5.20

1.0

1.1

0.05

0.08

u/ml

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

116

361

1.62

5.11

1.1

1.2

4.10

15.51

u/ml

0.86

261

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.26

5.09

3.5

2.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

317

1202

1.33

5.07

1.4

1.5

6.85

6.18

mmol/l

4.49

285

1073

(3036180) Methadone [Presence] in Urine

6.39

5.07

2.2

1.8

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.33

4.93

1.0

0.15

3.61

u/ml

1.30

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.77

4.89

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

3.12

4.86

1.0

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.60

4.84

1.0

0.17

0.18

u/ml

0.02

(3051101) Glucose [Moles/volume] in Cord blood

5.38

4.83

5.5

1.4

8.45

6.42

mmol/l

1.51

(3012441) Differential panel - Pleural fluid

124

399

1.56

4.79

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.26

4.73

1.4

1.2

—

(4015189) Microbial culture of sputum

2.48

4.71

3.6

1.8

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

4.68

1.3

0.0

29.33

—

mg/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.32

4.65

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.86

4.61

1.8

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.70

4.54

2.8

3.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.70

4.54

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.96

4.51

1.3

1.32

1.68

ml/s/173m2

0.69

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

133

1.97

4.40

1.0

1.1

0.60

0.67

u/ml

0.04

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.24

4.32

1.4

1.3

2.84

3.31

0.09

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.91

4.27

1.2

1.0

—

mmol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.03

4.26

3.4

7.8

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.74

4.16

7.3

3.7

35.79

44.87

ug/min

0.22

(40768441) Liver Pathology biopsy report

137

468

1.47

4.10

1.5

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

207

1.72

4.06

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

208

1.72

4.00

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

208

1.72

4.00

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.27

4.00

1.6

2.0

15.70

24.18

pmol/l

1.03

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.91

4.00

1.1

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.49

3.99

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.20

3.95

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.28

3.90

1.4

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.85

3.90

1.0

0.14

0.61

u/ml

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

111

1.99

3.90

1.0

0.01

0.02

u/ml

0.45

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

292

1.58

3.85

1.1

1.3

3.00

14.41

u/ml

2.66

212

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.29

3.84

4.5

4.4

—

(3000285) Sodium [Moles/volume] in Blood

2.38

3.77

1.2

138.71

138.49

mmol/l

0.09

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.57

3.73

1.3

1.1

—

(3014891) Appearance of Pleural fluid

2.63

3.73

1.8

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

213

1.68

3.71

2.2

1.8

0.17

0.21

nmol/l

0.43

161

(3045788) Cell count panel - Pleural fluid

116

392

1.49

3.70

1.4

—

(3035880) pH of Pleural fluid

183

1.73

3.69

1.3

1.2

7.39

7.40

0.09

123

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.01

3.66

1.3

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.43

3.65

5.9

8.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

107

1.97

3.65

1.0

1.1

3.69

9.71

u/ml

2.46

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.20

3.65

1.4

1.1

9.13

8.13

pmol/l

0.16

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1201

5379

1.13

3.60

3.7

5.4

11.12

41.65

ug/l

3.12

942

4172

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.22

3.58

3.1

4.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

158

571

1.39

3.56

2.2

20.93

28.24

ug/l

1.61

153

559

(40768806) Pleura Pathology biopsy report

116

396

1.47

3.54

1.6

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.52

3.53

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

366

1489

1.24

3.51

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

414

1.46

3.48

1.4

37557.55

34571.95

e6/l

0.07

246

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.14

3.44

1.0

1.1

7.53

15.37

u/ml

1.48

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

130

457

1.43

3.43

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.63

3.41

1.1

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

792

3464

1.15

3.41

1.6

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

314

1.52

3.39

7.0

10.0

163.87

8050.29

u/ml

0.61

(4211845) Urine protein measurement

290

1.54

3.39

2.3

2.1

—

(3002619) Bacteria identified in Specimen by Culture

130

1.82

3.26

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

145

1.77

3.25

6.8

6.2

5.93

6.03

kpa

0.46

135

(3026051) Granulocytes/Leukocytes in Pleural fluid

2.33

3.24

1.2

27.17

25.24

0.10

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

4.02

3.19

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.65

3.19

3.1

1.3

0.61

0.60

ug/l

—

(3015350) Toxocara sp Ab [Presence] in Serum

6.70

3.17

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

255

1.56

3.16

1.2

12.54

13.59

u/l

0.28

242

(40768800) Prostate Pathology biopsy report

181

1191

0.76

3.14

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

3.20

3.12

1.0

0.11

0.03

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

232

1.58

3.12

1.1

41.08

33.49

iu/ml

0.43

232

(3026692) Albumin [Mass/volume] in Peritoneal fluid

100

1.91

3.07

1.8

1.2

12.34

13.62

g/l

0.27

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

471

0.63

3.07

1.2

70.66

68.82

ug/l

0.10

471

(3025296) Carrot IgE Ab [Units/volume] in Serum

3.77

3.02

1.0

4.99

0.85

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.06

2.99

8.8

7.6

10.69

10.66

0.02

(3015076) Soybean IgE Ab [Units/volume] in Serum

203

786

1.30

2.98

1.0

1.1

0.32

1.03

u/ml

1.38

247

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.90

2.95

2.9

3.9

3.67

805.39

ug/l

0.54

(3011841) English Walnut IgE Ab [Units/volume] in Serum

169

1.67

2.94

1.1

1.2

7.26

7.69

u/ml

0.03

146

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

272

1.52

2.93

2.6

2.5

157.81

105.44

ng/l

0.75

196

(3027231) Wheat IgE Ab [Units/volume] in Serum

273

1.51

2.89

1.1

1.2

8.29

6.02

u/ml

0.11

261

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.77

2.89

3.7

7.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

1.77

2.75

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

3.68

2.75

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

260

1.51

2.75

2.2

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.59

2.74

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.68

2.73

3.4

3.8

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

577

0.69

2.71

6.9

6.6

8.20

8.62

0.24

577

(40761995) Spermatozoa Progressive [#/volume] in Semen

577

0.69

2.71

3.5

3.3

45.09

45.63

0.07

577

(3014599) Egg white IgE Ab [Units/volume] in Serum

213

842

1.27

2.71

1.1

1.2

2.38

8.17

u/ml

0.78

262

(3038071) Oxygen [Partial pressure] in Mixed venous blood

135

1.71

2.69

7.0

5.5

5.42

5.14

kpa

0.47

135

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

109

1.80

2.68

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.97

2.62

3.2

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.81

2.60

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.89

2.57

1.5

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.90

2.52

1.1

1.2

61.02

350.15

ug/l

1.22

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.38

2.49

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

343

1.41

2.43

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

117

1.72

2.40

1.1

1.2

0.28

0.89

u/ml

0.40

117

(3012989) Citrate [Moles/time] in 24 hour Urine

5.02

2.40

1.4

1.0

2.31

2.23

mmol/24h

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.77

2.38

2.2

2.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.04

2.38

1.1

1.38

2.02

mmol/l

1.36

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

120

448

1.35

2.35

1.4

1.5

5.40

5.01

mmol/l

4.10

113

433

(3013931) Oligosaccharides [Presence] in Urine

6.03

2.34

1.2

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

6.03

2.34

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.72

2.30

1.0

0.17

0.10

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

178

708

1.26

2.22

1.4

1.2

219.11

204.26

pmol/l

0.11

178

708

(3016135) IgD [Mass/volume] in Serum

3.48

2.22

1.4

1.0

22.37

28.55

mg/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

976

5380

0.91

2.21

1.6

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

213

868

1.23

2.17

1.1

1.2

1.20

2.68

u/ml

1.52

325

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.21

2.15

1.1

28.50

19.80

u/l

0.40

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.25

2.12

1.7

1.2

312.18

314.34

umol/24h

0.02

(40759632) Porphyrins [Mass/mass] in Stool

5.02

2.11

1.2

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.30

2.09

2.2

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

464

2035

1.15

2.07

3.2

4.6

5927.51

1496.23

u/ml

0.38

404

1788

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

393

1.34

2.07

6.0

8.6

15.16

17.80

ug/l

0.14

283

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.95

2.06

4.7

5.8

0.25

0.21

mmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.35

2.06

1.3

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.62

2.01

1.0

0.25

0.28

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

2.62

2.01

1.3

—

(3017509) Phencyclidine [Presence] in Urine

137

1.58

1.94

1.6

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.34

1.92

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.30

1.91

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.30

1.91

1.3

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1327

7164

0.93

1.90

1.5

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.51

1.87

1.0

0.10

0.11

u/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

268

1585

0.85

1.87

1.5

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.52

1.84

1.3

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

5.02

1.82

4.2

1.8

138.80

139.60

mmol/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.77

1.73

3.3

6.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.67

1.72

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

100

384

1.31

1.71

2.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.20

1.69

1.1

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.87

1.69

1.1

32.20

35.02

mg/24h

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.18

1.62

1.8

1.0

6.38

2.25

mu/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

194

812

1.20

1.61

1.6

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.35

1.57

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.93

1.56

2.1

1.2

2.36

1.51

g/l

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.18

1.55

1.0

0.12

0.71

u/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

121

1.54

1.55

1.3

1.5

5.53

5.32

mmol/l

0.69

121

(3002331) Protein [Mass/volume] in Peritoneal fluid

109

1.57

1.55

1.5

1.2

25.07

28.95

g/l

0.49

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

202

0.62

1.53

1.1

1.35

1.19

mom

0.37

202

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

224

955

1.18

1.53

3.6

4.6

135.85

1244.23

u/ml

1.98

211

875

(3016031) Almond IgE Ab [Units/volume] in Serum

106

1.56

1.50

1.0

0.32

1.81

u/ml

2.44

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.07

1.49

2.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.51

1.48

3.1

3.2

4.67

4.54

mmol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

132

538

1.23

1.45

1.4

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.76

1.45

4.2

2.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.85

1.44

1.0

0.82

0.85

mmol/l

0.02

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.38

1.41

12.3

9.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

780

4240

0.92

1.41

1.5

57.57

61.74

ug/l

1.99

780

4240

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

138

1.46

1.34

1.1

0.75

2.09

u/ml

0.86

103

(4212803) Bone marrow aspirate examination

2.26

1.34

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.51

1.32

5.3

2.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.70

1.32

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.95

1.32

2.1

2.3

280.71

212.23

ug/l

0.62

(3021691) Plasmodium malariae Ab [Titer] in Serum

3.14

1.30

3.4

2.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

3.14

1.30

1.2

1.1

431.40

388.37

mg/24h

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.77

1.30

2.9

1.6

0.83

0.63

u/field

0.33

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

1.38

1.27

2.7

1.5

1077.00

1223.00

e6/l

0.13

111

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.83

1.26

1.6

1.3

10.43

17.36

—

(4281824) Cell count and differential, peritoneal fluid

136

814

0.84

1.20

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.63

1.20

1.1

0.33

4.13

u/ml

1.07

(3020650) Glucose [Presence] in Urine

303

1.28

1.19

1.6

1.3

0.04

0.00

estimate

0.49

303

(4133840) Spirometry

220

1.32

1.17

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.79

1.17

1.0

1.4

32.10

44.21

umol/24h

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

351

0.76

1.16

1.1

—

(3044007) Cell count panel - Peritoneal fluid

156

1.38

1.14

2.0

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.71

1.11

5.4

2.8

2.61

1.67

mg/l

0.26

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.15

1.10

1.0

1.46

3.53

u/ml

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.75

1.07

2.1

4.7

6.48

69.01

pmol/l

—

(40768793) Breast Pathology biopsy report

337

1871

0.90

1.04

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.97

1.03

1.1

1.0

8.00

8.80

mmol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.01

1.03

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.07

0.99

1.1

1.4

780.26

295.00

nmol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.07

0.99

1.0

1.1

259.57

303.41

u/ml

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.61

0.98

1.1

40.89

49.55

mg/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

550

0.83

0.95

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.01

0.92

1.0

—

(40758292) HTLV I+II Ab panel - Serum

177

1.31

0.89

1.2

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.91

0.89

1.1

1.3

1.52

1.46

—

(3049233) Organic acids panel - Urine

1.78

0.84

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

157

1.31

0.84

2.5

1.5

4021.91

5087.58

e6/l

0.18

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

139

611

1.14

0.77

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

107

1.36

0.76

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

155

871

0.89

0.68

1.6

1.3

0.54

0.52

e9/l

0.47

155

871

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.65

1.3

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

309

1437

1.08

0.64

1.6

1.7

7.73

7.29

mmol/l

3.33

297

1379

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.88

0.61

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

973

1.09

0.60

1.9

2.2

162.65

1050.06

pmol/l

0.99

142

(3025130) Human papilloma virus identified in Specimen

400

1887

1.07

0.58

1.8

1.9

—

(3010937) Rubella virus Ab [Presence] in Serum

1.35

0.58

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.51

0.54

1.2

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.33

0.54

1.2

1.1

28.17

19.83

u/ml

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

115

0.74

0.52

1.1

1.0

167.71

163.70

g/l

0.50

115

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.60

0.50

1.1

—

(3032641) Amino acids panel - Urine

1.60

0.50

1.4

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.52

0.48

1.2

1.1

2.48

2.77

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

124

0.77

0.47

3.3

4.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

116

528

1.10

0.44

1.3

1.4

880.00

1035.09

titre

0.61

114

(46235168) Fasting glucose [Moles/volume] in Blood

109

1.24

0.44

1.5

1.1

7.46

5.16

mmol/l

—

(3046861) Legionella sp Ag [Presence] in Urine

1.57

0.42

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

107

488

1.10

0.40

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

139

1.19

0.38

1.4

2.2

1.31

3.82

ug/l

0.82

(3034614) HLA Ag [Interpretation]

1.51

0.37

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

150

699

1.08

0.36

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.30

0.36

3.4

3.1

99.13

100.03

g/l

0.10

(3003157) Bacteria [#/volume] in Mother's milk

1.38

0.35

7.3

7.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.30

0.31

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.31

0.29

1.2

0.14

0.16

umol/l

0.53

(3009677) Dengue virus Ab [Presence] in Serum

1.31

0.29

1.3

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

526

2559

1.03

0.28

1.4

1.3

3.91

3.71

ug/l

0.12

492

2402

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

236

1.09

0.19

1.1

1.0

6.99

7.34

kpa

0.79

211

(3004959) Base excess in Arterial cord blood by calculation

236

1.09

0.19

1.0

-1.85

-2.16

mmol/l

0.12

(3006598) pH of Arterial cord blood

236

1.09

0.19

1.1

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

232

1.08

0.17

1.1

1.0

3.69

3.49

kpa

0.18

205

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.85

0.15

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

108

1.12

0.15

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

203

1051

0.97

0.15

1.5

1.4

31.40

37.21

nmol/l

1.64

178

990

(3018738) Hemoglobin F/Hemoglobin.total in Blood

115

1.09

0.11

5.7

2.9

5.50

4.00

—

(3029396) Erythrocyte agglutination [Presence] in Blood

123

598

1.03

0.11

2.9

3.4

—

(3013862) HLA-DP [Type]

1.05

0.09

1.0

—

(40763590) HLA-DQ beta [Type]

1.05

0.09

1.0

—

(40768795) Lymph node Pathology biopsy report

136

665

1.03

0.09

1.3

1.2

—

(3022670) pH of Venous cord blood

1.11

0.08

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.11

0.06

1.1

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

129

1.05

0.05

2.5

2.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

336

0.99

0.01

1.7

2.2

—

(4038314) Semen analysis, post vasectomy

154

0.98

0.00

1.3

1.2

—

(40758358) Immune stain study

0.91

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

1.00

-0.00

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.00

-0.00

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

1.00

-0.00

1.1

1.3

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(40760410) HLA-B [Type] by High resolution

1.00

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: NEURODIS – Neurological diseases, wide definition

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neurological diseases, wide definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints